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ABSTRACT

INVESTIGATING THE IMPACT OF SMALL MOLECULES LIGANDS AND THE
PROTEOSTASIS NETOWRK ON PROTEIN FOLDING INSIDE THE CELL
SEPTEMBER 2016
KARAN S. HINGORANI
B.Sc., ST. XAVIER’S COLLEGE, UNIVERSITY OF MUMBAI
PhD., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Lila M. Gierasch
The folded forms of most proteins are critical to their functions. Despite the complexity
of the cellular milieu and the presence of high-risk deleterious interactions, there is a high
level of fidelity observed in the folding process for entire proteomes. Two important
reasons for this are the presence of the quality control machinery consisting of
chaperones and degradation enzymes that work jointly to optimize the population of the
folded state and interaction partners that re-enforce the functional state and add to the
competitive advantage of an organism. While substantial effort has been directed to
understand protein folding and interactions in vitro, comparatively little of these
processes are explored inside the cell. This work examines two important aspects of
protein folding inside the cell; first, the impact of small molecule ligands on protein
folding; and second, the impact of the proteostasis network on the folding of an
obligatory chaperone client. We deploy a combination of experiments and mathematical
modeling based on the principle of kinetic partitioning to understand how these
vii

phenomena sculpt the protein folding landscape inside the cell. We find that ligands
specifically deplete unfolded and aggregation- or degradation - prone protein populations
by favoring the folded state and the chaperone and degradation proteins work to
minimize off-pathway species thus reducing the population of aggregated protein inside
the cell.
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CHAPTER 1
INTRODUCTION

Proteins are essential biomolecules that execute vital cellular functions. For most proteins
to function correctly, they must fold into their correct three-dimensional shape and
interact appropriately with their partners. While much is known about protein folding in
in vitro systems, there remains much work to be done to understand how protein folding
occurs with fidelity inside the cell. In this chapter I will discuss some current progress on
the 1) status of protein folding research in vitro, 2) how protein folding inside the cell can
be vastly different from folding inside the test tube and the factors that can contribute to
protein folding in vivo, 3) the concept of kinetic partitioning which can be used to
understand how the differences in vitro and in vivo manifest in the folding reaction and
finally 4) the questions that I have tried to address during the course of my thesis which
are directed at understanding certain aspects of the cellular environment that influence
protein folding. Sections of this chapter were co-authored with my advisor and published
in the review “Comparing protein folding in vitro and in vivo: Foldability meets the
fitness challenge” Current Opinion in Structural Biology February 2014.

1.1. Protein folding in vitro:
In the sixty-odd years since Anfinsen’s pioneering work showing the ability of RNaseA
to re-fold from a reductively denatured state (Anfinsen, 1973), the mechanism of protein
folding and how amino acid sequence encodes a folding reaction have been extensively
studied (Daggett and Fersht, 2003; Dill et al., 2008). Increasingly powerful experimental
1

and computational methods have been focused on the intellectually seductive in vitro
‘protein folding problem’, defined to be the relationship between amino acid sequence
and the adoption of a native fold. As a consequence, we know a great deal about protein
folding, but our knowledge is largely confined to how a protein folds at high dilution in
conditions that are optimized for folding success.

Small fast-folding domains have been the subject of extensive in-depth study in vitro
because they are amenable to detailed physico-chemical analysis. For multiple reasons, it
might be anticipated that the intrinsic folding behavior of these domains will solely
determine their in-vivo folding properties. They fold on time scales (Daggett and Fersht,
2003; Hingorani and Gierasch, 2014; Zhang and Ignatova, 2011) that are much faster
(e.g., microseconds to milliseconds) than co-translational events (rate of synthesis in
eukaryotes 5 amino acids/sec, or 15 amino acids/sec in E. coli). Also, they generally do
not populate long-lived intermediates and do not present extensive hydrophobic
surfaces—both necessary for binding interactions with chaperones. If such domains
retain their intrinsic properties and their properties are not dominated by context, they
may be viewed as the “atomic particles” of well-folded proteins in the cell. This view
would allow researchers to treat large proteins as composites of smaller domains and, if
parsed into even smaller units, ‘foldons’ (Maity et al., 2005). Thus, the insights on
folding of small domains provided by ever more powerful experimental methods and
impressive new computational capabilities may be applicable to explaining folding in
vivo. For example, the description of transition path times using single-molecule Förster
resonance energy transfer (FRET) sheds light on timescales of fundamental folding
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events, and the promising simulations of folding at realistic timescales have afforded the
opportunity to compare experiment and theory directly (Chung et al., 2012; LindorffLarsen et al., 2011; Piana et al., 2013). Analysis of the folding trajectories computed by
Anton, the supercomputer designed for protein folding simulations, offered a unifying
mechanism for a dozen proteins and suggested that native-like contacts are formed in the
unfolded state, with successive stabilization of key contacts driving the folding reaction.
Progress in the simulation of folding reactions has also been reported by the Pande group,
who showed that Markov state modeling and molecular dynamics (MD) simulations,
accessible without Anton, generate kinetically relevant folding trajectories (Pande et al.,
2010). These researchers found evidence of glass-like kinetics using Markov state
modeling of folding (Weber et al., 2013). Computational studies such as these may
provide a possible bridge from theory to experiment.

However, small single domain proteins are quite rare; for example, they represent less
than 15% of the E. coli proteome (Braselmann et al., 2013). Moreover, recent work from
several groups suggests that, even though large proteins can generally be broken down
into smaller units by domain dissection, the folding of these component domains may not
be independent, and thus what is seen for free-standing small-domain proteins may not be
applicable to the universe of larger proteins in the proteomes of all organisms.
Specifically, the domains of repeat proteins have been found to display contextdependent folding (Sawyer et al., 2013; Vieux and Barrick, 2011). In addition, the
coupling of domains of large proteins is often a key part of the function of the large
protein (Ferreiro et al., 2011).

3

Thus it will be necessary to push the envelope of in vitro approaches and tackle larger
proteins to understand a the folding mechanisms of a greater population of several
proteomes. Some recent research has taken on this challenge, and results show how new
complexities in folding landscapes will emerge when larger proteins are examined: Pirchi
et al. deployed single molecule FRET coupled to hidden Markov analysis to uncover six
metastable states and multiple folding routes along the folding landscape of adenylate
kinase, a three-domain 23.5 kDa protein (Pirchi et al., 2011). The Rief laboratory used
optical tweezer pulling experiments and hidden Markov analysis to study the folding of
calmodulin and observed four on-pathway intermediates along with two off-pathway
intermediates that compete with the productive folding reaction(Stigler et al., 2011).
Dahiya and Chaudhuri (Dahiya and Chaudhuri, 2013) examined the folding of the 82 kDa
multi-domain protein, malate synthase G, and concluded that weak interdomain
cooperativity may add complexity to a folding pathway, including the possibility of a
functional intermediate.

Another research topic in in vitro folding that has seen impressive progress recently is the
nature of the denatured or unfolded state ensemble and under what conditions this
ensemble collapses.(Haran, 2012; Meng et al., 2013a; Meng et al., 2013b) A contentious
point has emerged regarding how collapsed the unfolded state ensemble is under differing
denaturant concentrations, and it now seems that the apparent results depend on the
method of observation (Yoo et al., 2012). In any case, it remains unclear whether and
when a polypeptide freely explores the unfolded state in vivo, apart from intrinsically
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disordered proteins. Domains may transiently unfold or populate non-native states as they
interact with chaperones (see below), and molecular machines that facilitate either
translocation across membranes or degradation likely actively unfold proteins (Baker and
Sauer, 2012; Tomkiewicz et al., 2007). Thus, the connections between non-native,
unfolded states in vitro and in vivo should continue to be explored.

1.2. Protein folding in vivo – what’s different?
Proteins initially fold in vivo upon their biosynthesis. Hence, the first environment they
are subjected to is created by the ribosome and ribosomally associated chaperone proteins
and enzymes. In addition, chains may fold co-translationally before the entire chain has
been made. In contrast, folding of proteins in vitro initiates from an unfolded ensemble in
which a population of full-length chains (or in the case of single molecule experiments,
one polypeptide) is subjected to folding conditions. Thus, the possibility of cotranslational folding constitutes a major difference between the de novo folding reaction
in the test tube and in almost all cells of living organisms.

Second, in vitro proteins sample their unfolded state in a dynamic equilibrium governed
by their thermodynamic stability. Whether proteins spend much time unfolded in vivo is
unclear. Many factors may disfavor accumulation of any significant population in the
unfolded state, including chaperone binding, ongoing degradation, and kinetic barriers.
Nonetheless, there may be lessons to be drawn from in vitro studies of unfolded states.

5

Third, protein-folding experiments in vitro are done at high dilution. In vivo,
macromolecule concentrations range from 200 to 400 mg/ml, and highly interactive
surfaces are present all around a folding chain are highly interactive. Thus, the impact of
crowding and the influence of protein-protein interactions, including weak “Quinary”
interactions (McConkey, 1982), must be taken into account (Figure 1.1).

Figure 1.1 Cartoon representation of the complexity found in an E. coli cell where
protein folding occurs
The figure depcits computational modeling by McGuffee and Elcock to capture the
crowded and heterogeneous environment of the E. coli cytoplasm. The modeling was
performed with 50 of the most abundant proteins in E. coli at atomistic detail (Plos comp
boil). Crowding in E. coli represents the high density of macromolecules and co-solutes
(discussed in the macromolecular crowding section in this chapter) that have co-evolved
with each other over the evolutionary time course. The high concentration of
macromolecules necessarily forces weak and transient interactions between them giving
rise to the term Quinary structure or if occurring in metabolic pathways – metabolons.

6
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Fourth, while proteins fold on their own in vitro, a significant fraction have ‘helpers’ in
vivo: molecular chaperones (Kim et al., 2013). It remains unclear to what extent and how
chaperones alter the fundamental folding energy landscapes of proteins (Figure 1.2).
Figure 1.2 Major components of the folding and degradation branches of the
proteostasis network in E. coli
A – GroEL (orange) and GroES (blue) (PDB 1aon) is homotetradecameric chaperonin of
the Hsp 60 family of chaperones. It is posited to act as a conduit for folding by providing
an environment for the unfolded polypeptide to fold without aberrant interactions with
other molecules inside the cell. The complete activity of GroEL occurs in the presence of
its co-chaperone GroES, which belongs to the Hsp 10 family of chaperones.
B- DnaK (purple – PDB 2kho) J domain of DnaJ (yellow – PDB 1xbl) and GrpE (red –
PDB 1dkg). DnaK belongs to the Hsp70 family of molecular chaperones. Substrate
binding and release by DnaK is controlled by the binding and hydrolysis of the nucleotide
ATP to the chaperone which triggers allosteric conformational changes causing substrates
to be released (ATP state) or bound (ADP state). DnaK is hypothesized to act on
misfolded (of-pathway) or unfolded polypeptides. DnaJ is a co-chaperone of the Hsp40
family; DnaJ interacts with substrate to deliver it to DnaK. GrpE is the nucleotide
exchange factor that accelerates the removal of ADP and incorporation of ATP into
DnaK.
C- Lon protease (PDB – 4ypl) is thought to be the major proteolytic enzyme that clears
misfolded species thus increasing the relative levels of folded proteins inside the cell. Lon
is also proposed to degrade off-pathway misfolded intermediates (Gur and Sauer, 2008;
Powers et al., 2012)

8
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Fifth, proteins are vulnerable to competing intermolecular aggregation reactions to an
extent that depends quite straightforwardly in vitro on the concentration of aggregationprone species. Aggregation also competes with folding in vivo, but translating the
parameters and mechanistic insights from aggregation studies in vitro to the in vivo
context must be done with caution (Figure 1.3).
Figure 1.3 Schematic for a coupled folding and aggregation landscape
The above figure shows the combined folding-aggregation energy landscape inside the
cell. Unfolded protein population serves as the progenitor of all states i.e. native/folded,
misfolded and aggregates all arise out of the unfolded state. As the protein sequence
codes for all states, the folding and aggregation landscapes become necessarily connected
and increasing protein concentration is a major driving force behind aggregation. Cellular
proteostasis is maintained by chaperones and degradation enzymes that favor the
formation of the native state and prevent the accumulation of aggregated or any other
non-productive states. Figure adapted from Hartl et al. 2009 (Hartl and Hayer-Hartl,
2009) and Jahn and Radford 2008 (Jahn and Radford, 2008).
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Lastly, folding reactions in vivo are spatially organized such that some interactions will
be preferred over others. In vitro it is very difficult to mimic a spatially organized,
inhomogeneous environment. This point is absolutely central to the folding of membrane
proteins, which, despite their importance, will not be a focus of this chapter.

1.3. Dissecting the factors that contribute to protein folding in vivo
1.3.1. Co-translational folding
How co-translational folding modulates the folding landscape of proteins (the landscape
of the whole chain, which defines the pathways to reach the native state or off-pathway
trajectories towards aggregation from the unfolded state) of proteins has been examined
in a number of recent experimental and computational studies. O’Brien et al. introduced a
computational approach to explore the impact of factors such as translation rate on
folding (Ciryam et al., 2013; Nissley et al., 2016). Their findings suggest that mutations
in mRNA that lead to altered translation rates may markedly alter folding outcomes. In a
follow up in the same study, this group compared folding of ribosome nascent chain
complexes that are arrested with those that are actively translating and concluded that at
in-vivo translation rates, one-third of E. coli proteins would fold co-translationally.
Krobath et al. also applied computational methods and found major impact of cotranslational folding of arrested chains versus chain fragments folding freely (Krobath et
al., 2013). They observed that the ribosome enhanced the population of low energy
conformations dominated by local interactions. The interrelatedness of translation rate
13

and folding points to a level of selective pressure acting at the RNA level. Experiments
with synonymous codons and ribosome display indeed point to the encoding of RNAlevel information, which might be woven together with the sequence code for folding in
vivo. The ribosome itself has been shown to affect folding (Ingolia et al., 2013; Shabalina
et al., 2013). Using single molecule force experiments, Kaiser et al. (Kaiser et al., 2011)
found that electrostatic interactions between the ribosome and their test protein (T4
lysozyme) retarded premature folding and allowed the nascent chain to remain in a
folding-competent state. Knight et al. (Knight et al., 2013) examined the dynamics of a
model nascent chain (a disordered protein) with varying charge and concluded that the
ribosome surface electrostatically influenced the behavior of the chain, causing nascent
protein variants carrying more negative charge to be more mobile. Recent studies by the
O’Brien group demonstrate the power of a computational model that predicts changes in
co-translational folding by the introduction of mutations in protein sequence that are
measureable by experiments (Nissley et al., 2016). Additionally, efforts directed at
understanding the structural aspects of co-translational folding have also revealed the role
of the ribosome in preventing misfolding and aggregation of certain substrates (Cabrita et
al., 2016; Deckert et al., 2016).

Viewing co-translational folding in terms of a naked nascent chain exploring
conformational space is, however, greatly oversimplified. A whole host of chaperones
(discussed in sections below) and quality control mechanisms lie in wait to greet the
emerging polypeptide chain and assist its folding. The nature of this ribosomally
associated greeting committee in E. coli has been reviewed by Bukau and co-workers

14

(Gloge et al., 2014). Their studies and others have revealed the order of events upon
‘birth’ of a nascent polypeptide, beginning with N-terminal processing, and followed by
chaperone interactions with trigger factor, the chaperone that has privileged access to
nascent chains of cytoplasmic proteins. These authors have provided compelling
arguments for an unfolding role of trigger factor, a ribosome associated chaperone, which
interacts with nascent chains (Hoffmann et al., 2012). Single-molecule pulling
experiments on maltose binding protein, Mashaghi et al. (Mashaghi et al., 2013) make a
strong argument that trigger factor promotes productive folding by protecting partially
folded states from misinteraction with neighboring molecules. The emerging role of
trigger factor in nascent chain folding is supported by computational work from Dobson
and colleagues, which posits that trigger factor interacts with emerging chains and retards
folding in addition to shielding the polypeptide from unfavorable interactions (O'Brien et
al., 2012). In eukaryotes, the Frydman lab has recently examined the co-translational
roles of Hsp70 in yeast through a global analysis of ribosome nascent chains (O'Brien et
al., 2012; Willmund et al., 2013). They found that Hsp70 interacted preferentially with
large multidomain proteins of complex topology that were unlikely to be able to fold cotranslationally, consistent with the function of Hsp70 in maintaining the nascent chain in
a folding-competent state.

1.3.2. Chaperones and proteostasis
Once a newly synthesized chain is away from the ribosome, it is further assisted by nonribosomally associated chaperones to ensure its successful folding and minimize
competing aggregation processes. While data have been rapidly accumulating on the
15

client repertoire of various chaperones in vivo, much less is known about how chaperone
interactions affect protein folding reactions. For example, recent studies have asked how
many and which proteins in E. coli are facilitated by the major chaperone systems
GroEL/GroES and DnaK/DnaJ/GrpE: The Hsp70 system interacts with 700 cytoplasmic
proteins, with particularly strong interaction with a subset of 180 that are aggregationprone (Calloni et al., 2012). GroEL/ES was found in a proteomic study to support the
folding of 250 proteins, with 84 of these obligatorily dependent on the chaperonin for
folding; a recent revisiting of this question concluded that there were fewer true GroEL
substrates (Kerner et al., 2005; Niwa et al., 2012), but the two studies agreed on the
nature of the obligate substrates: small enough to fit in the chaperonin cavity, and
enriched in metabolic enzymes and TIM barrels. Interestingly, Taguchi and co-workers
(Niwa et al., 2012)found using a cell-free system that the major E. coli chaperone
systems GroEL/GroES and DnaK/DnaJ/GrpE improved the solubility of 66% of their test
group of 800 marginally soluble E. coli proteins. These studies have provided insight into
the cellular dependence on chaperones for productive folding. How do chaperonesubstrate interactions sculpt folding landscapes? Single particle cryo-electron microscopy
has provided glimpses of substrates encapsulated in the GroEL chaperonin cavity,
suggesting that they are quite collapsed (Chen et al., 2013; Clare et al., 2009). Using in
vivo experiments monitoring growth as a criterion for fitness when mutant versions of the
essential protein dihydrofolate reductase were expressed in the presence of differing
amounts of GroEL/ES or the major protease Lon, Bershtein et al. (Bershtein et al., 2013)
concluded that both the chaperonin and the protease act on the molten globule
intermediate. These studies are consistent with current models in which GroEL
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smoothens the folding landscape of poor folders, while DnaK largely acts to unfold its
substrates, or maintain folding-competent or unfolded states (Kim et al., 2013; Saibil,
2013). There have been numerous efforts to determine the clients of Hsp90 chaperones,
and several labs have applied biophysical methods to deduce the nature of the binding
interaction and likely impact on substrate folding, but many questions remain for this
chaperone as well (Taipale et al., 2012). Data suggest that Hsp90 substrates are folding
intermediates with dynamic character. For example, p53 was observed to adopt a moltenglobule state upon interaction with Hsp90, and the model substrate staphylococcal
nuclease has been proposed to bind Hsp90 in an unfolded state via a local structural
element (Nissley et al., 2016). Similarly tau also interacts with multiple hydrophobic
contacts on Hsp90 suggestive of a late folding intermediate (Karagoz et al., 2014). The
elegant recent single molecule study of trigger factor-substrate interactions described
above demonstrated directly an unfolding activity – i.e. trigger factor unfolded the client
protein to allow a refolding reaction to occur (Hoffmann et al., 2012). The interactions of
small heat shock proteins with their clients have been a subject of constant examination,
but here also we lack mechanistic understanding about how these chaperones affect
folding. Similarly, the periplasmic chaperone HdeA binds molten globular substrates at
low pH but the consequent effects on their folding are as yet unexplored (Basha et al.,
2012; Foit et al., 2013; Hong et al., 2012). Strikingly, another periplasmic chaperone, spy
has been recently shown to allow proteins to fold while still being associated with the
chaperone (Stull et al., 2016). The eukaryotic chaperonin, TRiC, has to deal with larger
proteins than encountered in E. coli, and a recent study concludes that it binds partially
folded intermediates at domain boundaries, which helps explain how it may act on
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multidomain substrates but does not reveal details of its impact on their folding
(Russmann et al., 2012). Recent studies pioneered by the Kay lab (Sekhar et al., 2015,
2016) have found that DnaK keeps substrates in a more extended conformation yet
allowing the substrate to retain some of the local secondary structure it has in the
unfolded state. All told, current understanding of the impact of chaperone interactions on
the folding landscapes of proteins remains incomplete, and the confluence of data and
ideas from both in vitro and in vivo experiments will be needed to shed further light on
this key question.

Chaperones work in teams and in partnership with degradation enzymes to facilitate
folding in vivo and maintain protein homeostasis. A recent thrust is focused on admitting
the complexity of integrated chaperone networks to elucidate the impact on folding of a
substrate. A kinetic model centered on the major E. coli proteostasis components
(chaperones, degradation enzymes, disaggregase), beginning with a translated nascent
chain, has been developed jointly by Powers' and our labs (Powers et al., 2012). This
model called FoldEco enables generation of hypotheses about the involvement of the
proteostasis machinery and the folding success of a polypeptide when a few in vitro
parameters are known. Also, by implementing in vivo FRET on fluorescently labeled
chaperones Kumar and Sourjik (Kumar and Sourjik, 2012) were able to capture some of
the interplay between the chaperone systems in E. coli, thus showing that the quality
control systems are not isolated, but rather synergistic. The authors show how DnaK (or
Hsp70) seems to be a central player in the de novo and re-folding branches of the
proteostasis system.
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1.3.3. Evolutionary pressures
The canonical definition of ‘the protein folding problem’–viz., how is the information for
a protein folding landscape encoded in a given sequence– does not acknowledge the
many selective pressures that have led to the existence of that sequence in the proteome
of the organism from which it came. There is growing awareness of the importance of
understanding the impact of evolutionary selection on protein sequences and
consequently, their folding. It is not obvious when taken out of evolutionary context why
factors such as function, turn-over interactions would change the protein folding
landscape. Adding to the complexity is the fact that there are also many pressures acting
on base sequences, for example to adjust translation rate and to enable regulatory
processes to occur in transcription and translation (Li et al., 2012).

Protein stability naturally appears to be a property that would be selected for during
evolution (Serohijos et al., 2012). Using a theory-based and simulations approach,
Shakhnovich and colleagues make a strong case of how destabilizing mutations are
selected against in highly abundant proteins, thus explaining their slow evolutionary rate.
Yet, proteins designed in a laboratory generally display significantly higher stability than
naturally occurring proteins (Koga et al., 2012). This observation suggests that stability is
not the dominant driving force for sequence selection (Reynolds et al., 2013). A protein
must possess a number of other properties to survive a selection for organismal fitness.
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Perhaps the most obvious evolutionary pressure that impacts folding properties is the
requirement for function. Many have noted that the selection for folding and function
leads frequently to a trade-off (Dellus-Gur et al., 2013; Gosavi, 2013). Tawfik recently
noted that some folds, like TIM barrels, may possess a property, which he terms
polarization, that enables them to adapt to new functions (innovability) while maintaining
foldability and stability (Dellus-Gur et al., 2013). Mechanistic impacts of the foldingfunction tradeoff were postulated for interleukin-1β (IL-1β). Capraro et al. (Capraro et
al., 2012) observed that a functionally important structural feature, in IL-1β a β-bulge,
acts to shape the functional landscape so that only one folding route is followed, whereas
variants in which this bulge was mutated follow multiple routes.

Tawfik’s term ‘innovability’ may also apply to the ability of a protein evolutionary path
to lead to new folds. In a very thought provoking study, He et al. (He et al., 2012)
experimentally identified ‘mutational tipping points’ that enabled proteins to switch folds
and evolve new functions. On the other hand a study of ancestral thioredoxin proteins by
the Gavira group points out that although the ancestral protein differed considerably in
sequence from the present version and was more thermo-stable, it folds into the same
conformation as extant thiredoxins (Tokuriki and Tawfik, 2009). This highlights the
robustness of a protein sequence to tolerate destabilizing mutations yet fold to carry out
its function. It may well be an evolutionary advantage to retain this sequence nimbleness–
the ability to absorb mutations that may cause a change in fold or function, which may
improve organismal fitness, and in turn will have impact on the ‘winning’ sequences we
see in current proteomes. In a recent study with repeat proteins, Smock et al. (Smock et
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al., 2016) arrive at the conclusion that stability is inversely correlated with function,
which is not highly surprising given that an optimal balance between stability and
functionality decides the outcome of the protein sequence under evolutionary pressure
(Dellus-Gur et al., 2013; Koga et al., 2012).

The fine tuning of protein sequences to achieve the fittest fold and optimized function do
not operate in isolation in vivo. The idea that chaperones can buffer destabilizing
mutations that directly improve their function, or serve as stepping-stones to proteins of
improved function, has been experimentally supported (Tokuriki and Tawfik, 2009;
Wyganowski et al., 2013). Mapa and colleagues (Mapa et al., 2012) performed
experiments on a set of model substrates that populated kinetic intermediates and
demonstrated that each selectively bound its cognate chaperone from the whole spectrum
of E. coli chaperones present in lysate. They postulated that chaperone preferences coevolve with foldability of protein sequences. This notion was recently emphasized in a
provocative review on the origins of proteostasis (Powers and Balch, 2013). Furthermore,
the authors of this review, along with another, have pointed out that protein evolution
under the aegis of proteostasis is also environment dependent, and that integration of all
factors operating on an organism leads to proteomic diversity (Bogumil and Dagan, 2012;
Powers and Balch, 2013) (Figure 1.4).
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Figure 1.4 Evolutionary pressures changes the protein folding landscape inside the
cell
Protein folding in vitro can be thought of as navigating an energy landscape to reach from
a high-energy unfolded state to a low energy folded state. Hills and valleys along the
landscape represent kinetic barriers to protein folding which determine the speed at which
a protein folds/unfolds and the energetic difference between the top and bottom of the
landscape represents the folding free energy. In vivo the protein folding landscape is
subject to modification by a myriad of factors which include folding, function,
evolvability, and interactions with other biomolecules – all factors ultimately tying into
evolutionary optimization of protein to benefit the organism.
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Another factor that constrains sequence evolution is the requirement that proteins in vivo
form productive interactions and avoid non-productive interactions (Pastore and Temussi,
2012). A corollary of this selective pressure is the avoidance of pathological aggregation,
which may be viewed as a non-productive interaction. As noted recently by Levy et al.,
(Levy et al., 2012) the constraints on evolution of proteomes imposed by the need to form
productive interactions and to avoid non-productive interactions is enhanced under the
crowded conditions of the cell. A computational study by Yang and co-workers
postulates (Yang et al., 2012) that avoiding deleterious interactions causes abundantly
expressed proteins to evolve more slowly. In addition, evolutionary trends also suggest
that there has been a decrease in the fraction of hydrophobic residues and a tendency for
increased disorder within the proteome over time (Mannige et al., 2012). Such changes
may arise as a function of natural selection; however, they have consequences on folding
and protein-partner interactions. Furthermore, organization with favorable interaction
partners has been recently hypothesized to add to protein stability (Dixit and Maslov,
2013). This concept is similar to that of chaperones being evolutionary buffers as
discussed above, allowing proteins to accrue destabilizing mutations, yet fold and be
better at their function (Tokuriki and Tawfik, 2009).
1.3.4 Macromolecular Crowding, high density of co-solutes and quinary interactions
• Macromolecular crowding:
In vivo, proteins must fold and be stable in a heterogeneous environment as concentrated
as 400 g/L (Figure 1.1). Early hypotheses about macromolecular crowding placed heavy
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emphasis on the contribution of the void volume effects and its impact on the
enhancement of protein stability (Zhou et al., 2008). However, recent work by Pielak and
colleagues reveals that the influence of the crowded in-vivo environment may be
dominated by the prevalence of weak interactions, rather than the effects of excluded
volume from macromolecular crowding, as previously believed (Miklos et al., 2011b;
Monteith et al., 2015; Smith et al., 2016; Wang et al., 2012). These researchers found that
protein crowding agents (bovine serum albumin, lysozyme) destabilized a test protein,
CI2, in contrast to the stabilization expected from excluded volume effects (Miklos et al.,
2011a; Miklos et al., 2011b). Such effects are expected to be protein- and contextdependent, and indeed Guo et al. used a novel rapid laser temperature stepping method
capable of measuring complete thermal melts and kinetic traces in vivo to deduce that
phosphoglycerate kinase was more stable in mammalian cells than in vitro (Guo et al.,
2012). The seemingly contrasting results may differ because the experiments were
performed at different temperatures, and the entropic component of crowding is
temperature-dependent (Zhou, 2013). In addition, Dixit and Maslov (Dixit and Maslov,
2013) have argued compellingly that protein-protein interaction networks will stabilize
proteins in vivo relative to in vitro. Recent studies performed by the Oliveberg
(Danielsson et al., 2015) and Pielak (Smith et al., 2016) groups have provided a much
more detailed understanding of how the cellular environment and more importantly the
place of the protein in the a particular environment is an important factor determining
changes to protein stability when compared to measurements made in vitro. Using
elegant NMR experiments, the authors (Danielsson et al., 2015; Smith et al., 2016)
determine the impact of macromolecular crowding agents, the E. coli cytosol and cellular
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environment and the mammalian cellular environment on the stability of test proteins (the
SH3 domain and superoxide dismutase) and arrive at the conclusion that protein stability
in vivo is a function of multiple parameters – namely, protein surfaces, Quinary
interactions and in general the cellular milieu that interacts with the protein of interest.

• Quinary Interactions:
Protein function also involves the formation of higher order protein structures such as
quarternary and quinary structures (McConkey, 1982), which involve the proteins to
productively interact with each other. These higher levels of “folding” have long been
implicated in metabolic functions, where the resulting organized pathways were termed
'metabolons' (Roguev et al., 2013; Velot et al., 1997) and in signaling pathways. It had
long been hypothesized that the crowded cellular environment necessitates interactions
among biomacromolecules, and although such weakly associated complexes are difficult
to study in situ, and would be difficult to isolate, recent efforts have led to new methods
to interrogate them (Fraser et al., 2013; Lane et al., 2012). A recent study from the
Teichmann and Robinson labs (Marsh et al., 2013) utilizes nano-electrospray ionization
and gene fusion analysis to determine how several multimeric complexes are assembled
and disassembled. Through their analyses the authors find that the formation of
quaternary structure and protein assembly pathways also appear to be under evolutionary
pressure. Gruebele and colleagues (Wirth and Gruebele, 2013) have weighed in on
terming the panoply of weak interactions influencing a protein in vivo, both specific and
non-specific: 'quinary structure', as originally suggested by McConkey (McConkey,
1982) and re-introduced in an earlier review (Gershenson and Gierasch, 2011).
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• Inorganic ions and Metabolites:
The total concentration of cytoplasmic inorganic ions in E. coli is ~300 mM according to
the CyberCell database created by the Wishart laboratory (Sundararaj et al., 2004) . The
concentration of K+, by far the most abundant inorganic ion, varies drastically with
osmotic conditions. Two hundred millimolar is reported (Jewett and Swartz, 2004;
Record et al., 1998) to be physiologically relevant and CyberCell notes a concentration
range of 200-250 mM. Similarly, concentrations of Mg2+ have been reported, with
estimates ranging from 20 to 100 mM, although the amount of free Mg2+ is estimated to
be much smaller at 1 - 2 mM (Moncany and Kellenberger, 1981; Outten and O'Halloran,
2001; Tyrrell et al., 2013). Estimates for other common inorganic ions include Na+ at ~5
mM, Ca2+ at ~0.1 mM, and CyberCell reports concentrations of Cl- and total phosphate
(H2PO4-/HPO42-/PO43-) at 6 and 5 mM, respectively (Outten and O'Halloran, 2001;
Shabala et al., 2009). Although variations between tissues exist, average concentrations
of inorganic ions in E. coli, yeast and mammalian cells are in the same range.
Changes in intracellular ion levels can have pronounced effects on the conformational
properties of proteins and can have detrimental effects as seen in the enhanced
aggregation of a-synuclein at high salt concentrations (Hoyer et al., 2004). Growing
evidence suggests that changes in metal homeostasis and altered intrinsically disordered
proteins-metal interactions contribute to the pathogenesis of several neurodegenerative
disorders (Botelho et al., 2012; Breydo and Uversky, 2011; Kepp, 2012) suggesting the
critical balance that requires maintenance inside the cell. Indeed, many amyloidogenic
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IDPs such as α-synuclein, tau or amyloid β (Aβ) peptides directly bind metals, and metal
interactions modulate their in vitro aggregation behaviors (Theillet et al., 2014).

Recent advances in metabolomics technologies have allowed the concentrations of large
numbers of metabolites to be measured in E. coli (Bennett et al., 2009). In glucose-fed,
exponentially growing E. coli cells the combined concentrations of metabolites have been
estimated to be ~300 mM, with glutamate (Glu-) being the most abundant metabolite by
far (96 mM), followed by glutathione, fructose-1,6-bisphophate and adenosine
triphosphate (ATP) at 17 mM, 15 mM and 9.6 mM, respectively (Bennett et al., 2009).
However, these concentrations depend on the culture medium. By changing the carbon
source from glucose to glycerol or acetate, intracellular Glu- levels change from 96 mM
to 149 mM, to 45 mM, respectively (Bennett et al., 2009). Similarly, intracellular
glutathione concentrations change from 17 mM, to 18 mM, to 8 mM; Fructose-1,6bisphophate from 15 mM, to 6 mM, to <0.15 mM; ATP from 9.6 mM, to 9.0 mM, to 4.1
mM (Bennett et al., 2009). Significant variations in intracellular Glu- levels due to
changes in glucose levels in the growth media or due to changes in osmotic conditions
have also been seen in other studies (Cayley et al., 1991; Roe et al., 1998). When E. coli
cells were grown in McIlvaine's medium (minimal medium with citrate/phosphate buffer,
supplemented with thiamine and glucose) at pH 6, and harvested at mid-exponential
phase, the total concentration of all amino acids was determined to be ~90 mM, of which
Glu- comprises ~60 mM (Roe et al., 1998). In the presence of 200 mM glucose, Gluconcentration increase to ~117 mM. At 400 mM glucose, it is ~160 mM. By contrast,
CyberCell lists the combined E. coli concentrations of all 'small organic molecules' as 40-
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50 mM (undefined growth-medium and -stage), concentrations of free amino acids total
~15 mM, and ATP is indicated between 1.3-7.0 mM, depending on growth conditions
and sugar sources (Theillet et al., 2014). These numbers indicate the sheer abundance of
co-solutes and metabolites, all of which can influence the stability and interactions of
proteins inside cells.

Some metabolites such as glycerol, trehalose and zwitterions such as trimethylamine-Noxide, proline, betaine and ectoine, stabilize proteins at intracellular concentrations
between 100-300 mM (Bandyopadhyay et al., 2012). These compounds may represent a
special class of metabolites, termed ‘osmolytes’ because they also function as powerful
stabilizing agents in vitro. Nevertheless, these data indicate that metabolite concentrations
in the range of ~300 mM are sufficient to modify the properties of individual proteins.
While it is unlikely that metabolites generally induce folding of proteins in cellular
environments, they may modify the structural features of some of them. Furthermore, the
binding of these metabolites might shift the populations of proteins that exist in the
folded/unfolded state to selectively populate one or the other. Given the fact that proteins
with binding function are amongst the most populate class in the proteome, there remains
little light shed on how small molecule ligands can impact the folding fate of a large
fraction of the proteome.
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1.4. Kinetic partitioning – folding/aggregation/chaperone binding/ligand binding:
To understand how folding inside the cell differs from folding in vitro one has to consider
all the different parameters that can alter the folding of a protein and the fate of the
polypeptide chain in vivo. To fully capture the processes going on inside the cell, one has
to understand that the polypeptide sequence is under competition from the various factors
mentioned above. While the correct and functional folded state may be optimized by
evolution, protein levels, avoidance of aggregation and dependence on chaperones and
binding ligands can all be described by invoking a model of kinetic competition or kinetic
partitioning (Figure 1.5).
Figure 1.5 General schematic for the fates and the kinetic partitioning of a
polypeptide chain inside the cell
A synthesized protein (S) can fold co-translationally (not shown) or can fold to the native
(N) state from the unfolded (U) state. The U state is the progenitor for all states inside the
cell. The U state can misfold into an off pathway (M) state which has the propensity to
form protein aggregates (A). The N state has the capability to bind ligands (blue star) and
the M and U states can be degraded by cellular proteases. The transition from the U state
to any other state, or interconversion between states is principally governed by the
intrinsic rate constant for that conversion and the concentration of the species which acts
as a reactant in that conversion.
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A model of kinetic partitioning takes into consideration biophysical parameters and the
concentrations of the interacting components and uses a set of coupled ordinary
differential equations to establish relationships between folding outcomes and the impact
of the cellular environment on them. For example, one of the best-described model for
kinetic competition is FoldEco (Cho et al., 2015; Powers et al., 2012) (Figure 1.6).
Figure 1.6 The FoldEco model of proteostasis and kinetic partitioning in E. coli
The figure is a schematic of FoldEco which is a system of differential equations that
computes the flux of synthesized protein through different states (folded, unfolded,
misfolded, aggregated and degraded) in E. coli taking into consideration their intrinsic
folding and misfolding rate constants and how these proteins interact with the
proteostasis machinery of the cell, i.e. the association rates between different states and a
chaperone or degradation enzyme. It is a computational system which overlays the
chaperones and degradation machinery of E. coli on top of the kinetic competition that
naturally occurs for protein sequence. It serves as an important tool for generating
hypotheises as to how altering folding/misfolding properties can have an impact on the
folding fate of a protein inside the cell.
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FoldEco is a computational algorithm written to determine how the biophysical
properties of a protein interface with the proteostasis components to produce a given
yield of folded protein. The biophysical properties of the protein include the folding and
unfolding rate constants, misfolding and aggregation rate constants and equilibrium
constants for all those processes. The four states, folded, misfolded, unfolded and
aggregated, are a minimal set of states states that a monomeric protein can populate after
biosynthesis; one could add complexity by adding intermediates or treating multimeric
proteins, which could populate different oligomeric states. The program is specifically
written to incorporate the major components of the proteostasis machinery of Escherichia
coli, namely the two major chaperone systems, the GroELS and DnaKJE systems, a
disaggregation system which includes ClpB and DnaK and a mechanism for degradation
assumed to be catalyzed by the Lon protease. The proteostasis components have the
capacity to interact with three of the four possible states a protein can populate. The
interaction between the unfolded and misfolded states and the chaperone systems and
Lon are defined by association rate constants and the association of the aggregated state
with the disaggregation machinery is similarly defined. The program integrates all these
processes as coupled differential equations which when solved yield a theoretical output
of what to anticipate under a defined set of folding and proteostasis conditions. I will
discuss chaperone binding and the dependence of some proteins on chaperones to fold in
Chapter 3. By understanding how the protein partitions between folded and aggregated
states and with the knowledge of the chaperone concentrations, one should be able to
understand the impact of the proteostasis components on the folding of a test protein.
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Important, yet not fully captured by FoldEco is the impact of the metabolites and ligands
on the folded state of the protein. As mentioned earlier, ligand binding has the capacity to
shift the equilibrium that exists between different protein states in vivo. FoldEco also has
been focused initially on the fate of a single protein, but the program has the capacity to
consider competition among different folding clients for the protein homeostasis network.
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1.5 Statement of thesis
Despite the advances made in the field of protein folding, understanding how protein
folding properties interface with the complex cellular milieu remains insufficiently
studied. Most of our quantitative knowledge on folding comes from studies performed on
small well-folded proteins in dilute and purified environments. This approach, while
revealing the minutiae of the folding pathway, does not fully capture what could be
occurring inside the cell. Specifically, such studies do not capture the essence of kinetic
partitioning: protein sequences are have several possible pathways they can follow,
folding, aggregation, degradation, and the fate of the polypeptide chain depends on both
the intrinsic biophysical properties that govern the states a synthesized protein will visit
and how the cellular quality control machinery interacts with a synthesized polypeptide
chain so as to sculpt its landscape to favor folding and reduce detrimental outcomes. In
this thesis, we use a combined approach of experimental testing and mathematical
modeling to examine two aspects of the cellular environment that could affect the
successful folding of a synthesized protein . In Chapter 2, we dissect quantitatively the
effect of ligands on the folding fate of the protein. Our investigation seeks to capture
what could be happening to populations of multiple states that can be occupied by
synthesized protein in the presence of a high affinity ligand. We hypothesize that ligand
binding occurs after the protein successfully folds and that binding prevents nonproductive outcomes such as aggregation by effectively lowering the rate at which the
protein unfolds and populates an aggregation-prone state. We also hypothesize that the
remediation provided by the binding of the ligand is dependent on the relative
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biophysical properties of the protein and how it is the competition between populating the
folded state versus non-productive states that determines how effective the ligand, would
be. We further test our hypothesis using a system pertinent to human disease and where
protein degradation can be alleviated using a high affinity small molecule, an intervention
now dubbed pharmacological chaperone therapy. In Chapter 3, we investigate why
certain proteins obligatorily require the aid of chaperones to successfully reach the folded
state. To understand this, we utilized a test protein that obligatorily relies on one of the
chaperone systems to correctly fold and investigate how this protein’s folding outcome
changes when we alter the availability of different chaperone systems and degradation
machinery to the protein upon synthesis in the cell. Specifically, we work in E. coli, and
manipulate its two major chaperone systems, the GroELS and DnaKJE systems, and a
major degradation system (the Lon protease). We work in E. coli because it is a simple
organism with approximately 4000 genes and is capable of being grown and manipulated
to express varying amounts of protein in a facile manner. Using the above-mentioned
FoldEco model of proteostasis kinetic partitioning to explain the observed experimental
folding fate of the protein we deduced what the folding, misfolding and aggregation
parameters for such a chaperone-dependent protein were; parameters, which would not be
easy to measure in in vitro environments. Combining modeling results with experiments
monitoring the folding fate of our test protein, we were able to understand how ligands
and the intrinsic biophysical properties of a protein that obligatorily depends on cellular
proteostasis machinery affect the folding outcome of a protein to reach the folded state,
thus shedding light on the processes that govern protein folding inside the cell. In chapter
four we use our knowledge on ligand binding and enhancement of stability to build a
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protein folding sensor to measure protein thermodynamic stabilities inside the cell. We
discuss one approach for building such a sensor, the mutually exclusive folding model
and show how it can be implemented using a suitable protein – ligand pair as a starting
point for our sensor. We then go on to show preliminary experiments that utilize our
folding sensor in vitro and in vivo to demonstrate that such a construct can theoretically
be used to test protein stability and the limitations associated with the use of a mutually
exclusive folding construct as a sensor for protein stability measurements.

38

CHAPTER 2
INVESTIGATINGT THE IMPACT OF SMALL MOLECULES ON PROTEIN
FOLDING INSIDE THE CELL

This chapter investigates how the presence of a high affinity ligand biases the
competition between folding and aggregation to favor the folded state, thereby reducing
the effective unfolding rate and preventing the channeling of protein into non-productive
pathways such as aggregation or degradation. The work for this chapter was performed in
collaboration with Matthew Metcalf, Scott Garman and Evan Powers, and has been
submitted for publication.

2.1. Introduction
Cellular proteins are bathed in a sea of diverse ligands ranging from other
macromolecules to metabolites. The intracellular concentration of macromolecules is
high, up to 400 mg/ml in bacteria and eukaryotic organelles, and small molecules such as
metabolites are also present at high concentrations inside cells. For example, in glucosefed E. coli, glutamate, ATP, glutathione, NAD+ and other metabolites are present at
millimolar levels (Bennett et al., 2009; Gershenson and Gierasch, 2011). Thus, in a
normal physiological milieu proteins participate in binding reactions and equilibria with
many other intracellular solutes; these binding interactions range from strong, specific
interactions to weak, transient interactions. Surprisingly, little attention has been paid to
the impact of these many binding interactions on the folding energy landscapes of
proteins in the cell, despite active research directed towards enhanced understanding of
protein folding in cells (Bershtein et al., 2015; Bershtein et al., 2013; Cho et al., 2015;
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Dixit and Maslov, 2013; Hingorani and Gierasch, 2014; Kim et al., 2013; Monteith et al.,
2015). It is in the intracellular environment that is replete with co-solutes that proteins
must successfully navigate an intersecting folding – aggregation landscape to reach their
functional folded states (Jahn and Radford, 2008). In addition, small molecules added to
cells exogenously as potential therapeutics will influence the folding – aggregation
landscape. In the present study, we have explored the impact of ligand binding on folding
in the cell using two simple test systems, combining experimental and mathematical
modeling approaches to gain insight into the magnitude of the effect of ligand binding on
the partitioning of the test protein between proper folding and aggregation.

2.2. An aggregation-prone dihydrofolate reductase mutant can be rescued using a
high affinity ligand
To determine the effect of a high affinity ligand on the kinetic balance between folding
and aggregation, we chose to work with a destabilized version of E. coli dihydrofolate
reductase (dDHFR) as our test protein. dDHFR was destabilized by the introduction of
two glycine residues in a surface loop between residues 106 and 107 (Figure 2.1A). The
mutation did not perturb any residues in the ligand-binding site. We tested the affinity for
the ligand trimethoprim using an intrinsic (present in the DHFR molecule) tryptophan
fluorescence quenching assay (see methods) and found that the our mutation had only
slightly perturbed affinity for this ligand (approximately 40 nM compared to 8 nM as
reported in literature by (Watson et al., 2007)) (Figure 2.1C). Upon over expression in E.
coli BL21(DE3) cells, dDHFR largely (80%) aggregated in the absence of any added
ligand. Strikingly, the presence of a non-hydrolysable analog of the natural DHFR
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substrate trimethoprim (TMP) during protein synthesis re-partitioned the protein to the
soluble fraction to a large extent (Figure 2.1D).
In vitro characterization of dDHFR revealed a ΔΔG of approximately 3 kcal/mol with
respect to wild type (Figure 2.1B) (Ionescu et al., 2000) at 37 o C. The equilibrium free
energy of unfolding was determined as a function of increasing concentration of
trimethylamine N-oxide (TMAO) by performing urea denaturation experiments at desired
concentrations of TMAO. Extrapolating the free energy to 0 TMAO allowed us to
calculate the ΔG to be about 0.5 kcal/mol at 37 o C (the equilibrium stability measured by
urea denaturation experiments of wildtype DHFR measured at 37 o C was reported at 3.5
kcal/mol) . This translates to roughly 70% of the protein population being folded at
equilibrium, suggesting that the protein tended to significantly populate the unfolded state
even at equilibrium. Together with our in vitro and protein expression data, the dDFHRTMP seemed to be an ideal model system to test the impact of a high affinity ligand on
the kinetic partitioning between folding and aggregation.
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Figure 2.1 dDHFR is a destabilized test protein the solubility of which is improved
upon addition of a high affinity ligand trimethoprim.
A. Test protein dDHFR (PDB 7dfr) with a gly-gly insertion between residues 106 and
107 (highlighted in red) and the cognate ligand trimethoprim, which mimics substrate and
is a competitive inhibitor.
B. Fluorescence quenching of dDHFR (50 nM) upon titration with TMP enables the
calculation of the fraction of dDHFR that is bound at each TMP concentration. The error
bars for the individual data points represents the standard error of the mean from
triplicate measurements. Fitting single site binding model to the data yields an estimated
equilibrium dissociation constant (Kd) of 37 ± 6 nM. The error in Kd is the standard error
of the best fit parameter based on the fit to the averaged data.
C. Stability of dDHFR was measured at varying TMAO concentrations as a function of
urea concentration. Extrapolation from stabilities measured at different TMAO
concentrations yields ΔG (folding free energy) at 37 oC to an average of 0.5 kcal/mol
which is a ΔΔG of ~ 3 kcal/mol compared to wildtype (Ionescu et al., 2000).
D. dDHFR synthesized in the absence of ligands partitions predominantly to the
aggregated fraction, however presence of the high affinity ligand trimethoprim (0.8mM
in the above sample) redistributes dDHFR to now be mostly soluble.
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2.3. Testing the reversibility of aggregation and ligand binding inside the cell
We next tested if the effect of TMP had to do with prevention of dDHFR from forming
aggregates, or whether the ligand caused a rescue from the aggregated state. Secondly,
we also wanted to determine if the dDFHR-TMP complex formed inside cells was
essentially irreversible formed on the time scale of our experiments, or transient and
readily dissociated. We performed chloramphenicol shut-off experiments to answer both
questions (Aakre et al., 2013). We shut off translation using chloramphenicol and
replaced the media containing TMP with fresh media containing no TMP. We
hypothesized that if the dDHFR-TMP complex dissociated, then we would observe a rise
in the aggregated fraction of the protein. Similarly, we shut off translation in the presence
of high concentrations of TMP (80 µM). As TMP is added to the outside of cells, it acts
as a large reservoir of ligand. Our hypothesis in this case was that if the aggregates of
dDHFR were disaggregated and re-dissolved upon addition of TMP, we would observe
an increased level in the soluble protein even after the protein had aggregated inside the
cell. Both treatments were allowed to proceed for an hour before interrogating the soluble
and insoluble fractions (Figure 2.2). From both experiments we could conclude that on
the time scale of our experiments, the dDHFR-TMP complex was stable in cells (no
increase in aggregates upon depletion of TMP) and that the aggregate that formed could
not be re-dissolved by the addition of high TMP concentrations, indicating a lack of
rescue from the aggregated state (Figure 2.2). Our model could now treat these two
processes (aggregation and ligand binding) as irreversible.
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Figure 2.2 Chloramphenicol shut-off experiments
irreversibility of ligand binding and aggregation

indicate

the

effective

A. The partitioning of dDHFR in the presence of TMP before and 1 hour after stopping
translation with chloramphenicol (CAM). T = total dDHFR in all forms; P = aggregated
dDHFR in the pellet after centrifugation at 18,000×g for 30 min; S = soluble dDHFR in
the supernatant after centrifugation at 18,000×g for 30 min. Gels were stained with
Coomassie G-250. The numbers above each lane are the mean ± standard error in the
fraction of protein present in the corresponding states for three trials. In the presence of
TMP, the protein found in the aggregate does not redistribute to the soluble fraction over
the 1 hour.
B. As A, but showing the partitioning of dDHFR in the presence of TMP, and 1 hour
after stopping translation and changing the media to remove TMP. Removal of the TMP
does not re-partition the soluble dDHFR into the aggregate fraction over 1 h. The
associated bar graphs show the average aggregated and soluble fractions of three
measurements and the associated standard error of the mean.
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2.4. A mathematical model allows us to hypothesize the effect of high affinity ligands
on the kinetic partitioning of their cognate proteins (developed by Evan Powers)
In the model in shown in Figure 2.3, the protein is synthesized at a rate σ (µM s−1) and
released from the ribosome in an unfolded state (U), which can fold reversibly to the
native state (N) with folding and unfolding rate constants kf and ku (both s−1),
respectively. The unfolded state can also aggregate through visiting some off-pathway
misfolded intermediate which rapidly self associates to form aggregated protein (Agg).
Each of these processes is treated as being irreversible (based on our chloramphenicol
shut-off assays and the fact that degradation is an irreversible process) and having a firstorder rate limiting step with the rate constant kagg (s−1). The native state can bind to a
ligand to form a complex (N:L). Again based on our controls (described in the previous
section), we treat this process as irreversible, with a second-order association rate
constant ka (µM−1 s−1). The model described here is not just limited to a competition
between folding and aggregation but in general competition between folding and other
pathways a polypeptide chain can visit inside the cell. Shown in Figure 2.3 is also the
competition between folding and degradation (for example, Endoplasmic Reticulum
Associated Degradation, ERAD) where again, the unfolded population of the protein is
the progenitor to states that are degraded (Deg) with a rate constatn kdeg (s-1) . As
degradation is intrinsically an irreversible process, we can account for it in the same
fashion we used for the cytosolic folding – aggregation competition. Finally, the native
state (free or ligand bound) can in some cases (depending on the organelle of interest) be
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secreted with a first-order rate constant ksec (s−1). We assume that the turn-over rate of
secreted protein (Sec) is much longer than the time scale of the experiment so that
degradation after secretion is negligible. Also, we assume that the intracellular
concentration of any ligand that is present is constant because there is a large reservoir of
ligand in the media and the ligands rapidly equilibrate across the cell membrane. Thus,
the “terminal states” in this model, that is, the states in which protein will continue to
accumulate indefinitely, are the degraded, aggregated, and secreted states. If there is no
secretion, then the ligand-bound native state (N:L) will be a terminal state rather than the
secreted state.
We thank Evan Powers for generously providing the mathematical rigor to our model and
the detailed steps are noted in the appendix.
The fraction of protein that remains soluble (i.e., is not degraded and does not
aggregate) at a given time is straightforward to measure experimentally. We refer to
this quantity as Fr. We replace Fr with either Fsoluble or Fpreserved depending on the
competition (folding vs aggregation or folding vs degradation) under investigation.
When a ligand is present, the system rapidly reaches a “pseudo-steady state” in
which the concentrations of U and N are constant and Deg, A, N:L, and/or Sec
accumulate at a constant rate. Fr can then be written as follows

𝐹! = 1 −

! ! ! !"# !
!!"! !

!

=1−
!!!!

(1)
!

!!

!
!! !!! !

Where [A]t and [Deg]t are the concentrations of aggregated and degraded protein at
time t; [Ptot]t is the total concentration of protein that has been synthesized at time t;
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[L] is the ligand concentration; B1 = kf/(kagg + kdeg); B2 = ksec/ku; and B3 = ka/ku. In the
absence of a ligand, pseudo-steady state is reached more slowly and Fr is time
dependent. An approximate expression for Fr under these circumstances is:

𝐹!| ! !! = 1 −
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!!
!!!!
!!!!

+

!

!!!!
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!!!!

!!
!!!!

−1

(2)

This expression does not hold at early time points, but the approximation improves
with time as the system approaches steady state (see Appendix). Equation (2)
becomes identical to equation (1) with [L] = 0 at very long times (kut >> 1).
Equation (1) provides a framework for understanding the effect of ligand binding on
protein partitioning to folding, degradation and aggregation in vivo. Importantly, it
predicts that Fr increases with the ligand concentration until it reaches the following
limit:

𝐹!|[!]→! = 𝐹!,!"# = 1 −

!
!!!!
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Thus, at very high ligand concentration, a protein’s partitioning becomes purely a
matter of kinetics and is no longer dependent upon folding thermodynamics.
Specifically, Fr is controlled by the relative values of kf vs. kagg + kdeg.
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Figure 2.3 General schematic of the kinetic partitioning influenced by ligand
binding
The schematic describes the kinetic partitioning of a protein upon synthesis in the
presence of a high affinity ligand. The species in the model are: U, unfolded protein; N,
natively folded protein; N:L, ligand bound natively folded protein; Deg, degraded
protein; A, aggregated protein; Sec, secreted protein. The total protein synthesized, Ptot,
includes all of these states. The rate constants are: σ, protein synthesis rate (µM s−1); kf,
folding rate constant (s−1); ku, unfolding rate constant (s−1); ka, protein–ligand association
rate constant (µM−1 s−1); kdeg, degradation rate constant (s−1); kagg, aggregation rate
constant (s−1); ksec, secretion rate constant (s−1).
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2.5. Testing the hypothesis of an upper limit on aggregation prevention in the DHFR
–TMP system.
We tested our model by titrating increasing concentrations of TMP into cells expressing
dDHFR. As described by equation 1, we saw a titratable rise in the Fr as a function of our
ligand concentration up to a certain limit beyond which any addition of ligand does not
cause any increase in the amount of protein that aggregates or remains soluble (Figure 4).
Given our observations, it is reasonable to conclude that the parameters from the fit of
equation (1) accurately reflect the biophysical properties of dDHFR inside the cell. Of
particular interest is the value of B1, which is 2.9 ± 0.8 = kf/(kagg + kdeg) = kf/kagg (the
BL21 strain of E. coli lack Lon protease which is mainly responsible for DHFR
degradation (Bershtein et al., 2013; Cho et al., 2015), so kdeg = 0), because it reveals that
folding is about three times faster than aggregation. According to equation (3), this ratio
controls the maximum extent to which TMP can rescue the folding of dDHFR. No matter
how high the concentration of TMP is, a portion of the dDHFR will be diverted to
aggregation before TMP binding can rescue it; for dDHFR, that portion is about 25%
(Figure 2.4B).

The dDHFR expression experiments were 90 min long (t = 5400 s). Given that B1 = 2.9 ±
0.8 and that Fr|[L]=0 = 0.15 ± 0.02, equation (3) can be solved for ku to yield ku = 0.0035 ±
0.0010 s−1. This value of ku is consistent with unfolding rate constants measured for other
destabilized DHFR variants. However, it should be noted that dDHFR can bind to a
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second ligand, the coenzyme NADPH. The effects of this ligand on dDHFR’s behavior
are subsumed into the folding energetics, and in particular into the effective unfolding
rate constant.

Figure 2.4 Titration of TMP shows that dDHFR Fr scales with concentration of
TMP and plateaus as a function of its intrinsic folding and aggregation rate
constants
A. SDS PAGE gels showing that the titration of TMP shifts the dDHFR population from
mostly aggregated to mostly soluble in a dose dependent manner.
B. A plot of Fr vs. TMP concentration after expression for 90 min in E. coli BL21 (DE3)
cells at 37 °C (open circles). The solid curve is the fit of equation (40) to the data with
B1( kf/(kagg + kdeg)), = 2.9 ± 0.8, B3 = 0.048 ± 0.025 µM−1, and R2 = 0.84. The value of Fr
at [TMP] = 0 is shown as a filled red circle. The dashed line represents the maximum
value of Fr according to equation
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2.6. Testing the model on a pharmacological chaperone – The alpha galactosidase
and DGJ model
The chemical chaperone 1-deoxygalactonojirimycin (DGJ) is currently under
investigation as a pharmacological chaperone therapy for Fabry disease (Benjamin et al.,
2009; Khanna et al., 2010; Wu et al., 2011). DGJ has been shown to increase the cellular
concentrations and activity of several disease related α-galactosidase (α-GAL) point
mutants in cell culture experiments (Benjamin et al., 2009; Wu et al., 2011). We reasoned
that the intracellular rise in protein concentration was a manifestation of the impact of
ligand binding on the kinetic competition between folding and degradation for the mutant
α-GAL proteins. We tested the effect of increasing concentrations of DGJ on the
intracellular protein levels of α-GAL R301Q (a mutation associated with late onset Fabry
disease) in HEK cells (Fig 2.3A,B). Predictably, the levels of α-GAL increase with
increasing concentrations of the pharmacological chaperone until a saturation point,
analogous to what was observed in the DHFR experiment (Figure 2.5). To determine the
level of α-GAL in the absence of any degradation we used the proteasome inhibitor
lactacystin in one of our samples. Predictably, when compared to the sample with the
added proteasome inhibitor, the levels of α-GAL increase with increasing 1-DGJ
concentrations until a saturation point is reached (Figure 2.5A), analogous to what was
observed in the dDHFR experiment and consistent with the predictions of equation (1).
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α-GAL R301Q does not aggregate intracellularly (kagg = 0), B1 = 1.24 ± 0.08 = kf/(kagg +
kdeg) = kf/kdeg, indicating that degradation and folding are almost evenly poised.
According to equation (1) and using this value of B1, the maximal rescue possible for αGAL R301Q is approximately 55% of the protein. Unlike dDHFR, the best fit of equation
(1) to the α-GAL R301Q expression data is still very good at low ligand concentrations,
indicating that the system reaches pseudo-steady state over the 24 h time course of these
experiments (Figure 2.5B).
Figure 2.5 Titration of DGJ shows that α-Gal Fr scales with concentration of DGJ
and plateaus as a function of its intrinsic folding and degradation rate constants
A. Western blot showing the increase in alpha galactosidase levels upon titration with
DGJ, lac is proteasome inhibitor lactacystin as our 0 degradation sample to which the
increase in protein concentration brought about by the ligand is compared to. The
different bands observed represent the differentially glycosylated species.
B. A plot of Fr vs. 1-DGJ concentration after expression for 24 h in HEK 293T cells at 37
°C (open circles). The solid curve is the fit of equation (1) to the data with B1 = 1.2 ± 0.2,
B2 (ksec/ku) = 0.33 ± 0.11, B3 = 0.14 ± 0.10 µM−1, and R2 = 0.88. The value of Fr at [1DGJ] = 0 is shown as a filled red circle. The dashed line represents the maximum value
of Fr according to equation (3)
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2.7. Conclusions about ligand binding
This study has broad implications for how pharmacological chaperones function and may
provide explanations in cases where they do not ameliorate protein misfolding diseases
where the ratio of the folding rate constant to the sum of the aggregation and degradation
rate constants is less than one. Migalastat (DGJ) is a well known pharmacological
chaperone that improve the folding of the α-galactosidase mutants implicated in Fabry
disease, respectively (Benjamin et al., 2009; Ishii et al., 2007). However, there are many
variants of these proteins that are unresponsive to pharmacological chaperone therapy
(Wu et al., 2011). We posit that a simple mechanism that invokes increased
thermodynamic stability upon ligand binding is not sufficient to explain how such
molecules work. To completely understand the mode of action of pharmacological
chaperones it is imperative to understand the kinetic partitioning between productive
(folded) and non-productive (aggregated/degraded) outcomes. We argue that
pharmacological chaperones would be most effective on proteins where the rate of
folding is not the limiting step, i.e. the protein needs to fold faster than it aggregates or is
degraded so that the small molecule can bind it and prevent the partitioning into nonproductive states. Thus, to put forward a molecule as an effective pharmacological
chaperone requires knowledge of how the molecule alters the kinetic competition of the
protein it targets rather than just the affinity with which it binds.

A case in point is the limited success of pharmacologic chaperones as monotherapies for
cystic fibrosis, which is caused by mutations in the cystic fibrosis transmembrane
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conductance regulator (CFTR) (Clancy et al., 2012). CFTR is a large membrane protein
that folds very slowly, and as a result a substantial fraction of even wild type CFTR is
degraded before it can be exported (Lukacs et al., 1994). This situation is worse for
CFTR mutants, many of which partition almost exclusively to ERAD leading to loss of
CFTR function (Lukacs et al., 1994; Ward et al., 1995). Treating cells expressing a
common disease-associated mutant (ΔF508 CFTR) with lumacaftor, a small molecule
that binds CFTR, modestly increases the trafficking of CFTR to the cell surface (to 14%
of wild type levels) (Van Goor et al., 2011). In terms of our model, this “low ceiling” for
the efficacy of a pharmacologic chaperone for ΔF508 CFTR is an unavoidable
consequence of its slow folding, and it suggests that alternative strategies for improving
ΔF508 CFTR trafficking—for example, using proteostasis regulators either to increase kf
(by improving chaperoning) or decrease kdeg (by inhibiting ERAD)—could yield
improved results (Powers et al., 2009).

The influence of ligand binding on the energy landscapes for folding and
aggregation/degradation is a widespread phenomenon in nature, and ligands often
shepherd a protein towards well-folded states. For example both antibody heavy chain
and light chain diseases are caused by insufficient amounts of their binding partners.
Similarly, β-2 microglobulin aggregation is triggered by its dissociation from the heavy
chains of MHC ClassI molecules (Eichner and Radford, 2011). Ligand binding can also
cause transitions from an unfolded state to a more ordered state. In an elegant study
Daniels et al. (Daniels et al., 2014) demonstrate how the ligand pyrophosphate drives a
conformational change of the disordered protein Bacillus RNaseP from unfolded to
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folded. Such binding of ligands can provide an additional layer of protection against
aggregation as seen in the case of Tau, where the microtubule binding region and the
region implicated in aggregation are the same (Mukrasch et al., 2005). Lastly, the impact
of binding on the ability of proteins to withstand mutations without succumbing to
deleterious consequences places ligands in the category of “evolutionary buffers”; in the
same manner as chaperones, ligands may allow proteins to mutate via steps that would
otherwise be highly risk prone in an evolutionary pathway (Gershenson et al., 2014). To
this effect a small summary of examples where ligand binding alters the kinetic
partitioning of proteins between folding and non productive states such as aggregation or
degradation is listed in Figure 2.6.

Figure 2.6 Other prominent studies showing how natural and artificial ligands bias
the folding – aggregation – degradation kinetic competition for other proteins
The above table shows a few representative examples of how ligands have shown to alter
the aggregation or degradation of the proteins they bind to. Essentially, the presence of a
ligand is shown to favor the folded form, but our analysis shows that this is only possible
because folding is not the rate limiting step for these proteins.
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Ray et al. 2005
Saliba et al. 2002
Banaszynski et al. 2006

2.8. Materials and methods
• Cloning, expression, and purification of dihydrofolate reductase.
The wild type cysteine-free E. coli dihydrofolate reductase (DHFR) gene was a gift from
the Matthews lab (University of Massachusetts, Medical School, Worcester MA)
(Ionescu et al., 2000). It was subcloned into the pET28 expression vector using NdeI and
BamHI restriction endonuclease sites. The -glycine-glycine- insertion between residues
K106 and A107 was introduced by site-directed mutagenesis using a QuikChange
protocol (Stratagene) yielding the “dDHFR” mutant. The vector was transformed into E.
coli BL21 (DE3) cells. Cultures were grown at 37 °C to optical density at 600 nm
(OD600) of 0.6, induced with 1 mM final IPTG concentration and expressed at 37 °C for 4
h. The cells were harvested by centrifugation and re-suspended in buffer containing 20
mM HEPES, pH 7.4. The cells were lysed using a microfluidizer, and the protein was
purified by refolding from inclusion bodies. Inclusion bodies were dissolved in 8 M urea
and subsequently dialyzed to refold the protein, which was further purified using anion
exchange chromatography on a DEAE column using a 0 M to 1 M sodium chloride
gradient. After elution, the salt was removed by dialysis and the protein was flash frozen
and stored at −80 °C until further use.
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• In vitro trimethoprim binding assay for dDHFR.
The in vitro trimethoprim (TMP) binding assay was performed with 50 nm purified
dDHFR following the protocol from Watson and co-workers (Watson et al., 2007).
Briefly, dDHFR was incubated with increasing concentrations of TMP and the degree
of quenching of dDHFR intrinsic tryptophan fluorescence was monitored at 345 nm.
Spectra were corrected for any contribution to the fluorescence by TMP by running a
parallel titration without protein. Fraction bound was calculated by using the formula
below.

Fbound =

fluorescencemeasured − fluorescencemax
fluorescencemin − fluorescencemax

• Measurement of dDHFR thermodynamic stability.
dDHFR was titrated with increasing concentrations of urea (0 – 8 M) in the presence of a
final TMAO concentrations of 0.7, 0.8, 0.9, 1, 1.2 and 1.5 . The titrated samples were
incubated at 37 o C over 10 hours. Fluorescence was collected from 320 to 380 nm after
specific tryptophan excitation at 295 nm. Intensity at wavelength 344 nm was used to fit
the data to the two-state equation (Bolen and Santoro, 1988) to obtain thermodynamic
stability. All solutions were prepared with 20 mM HEPES pH 7.4, and the urea
concentration was measured using its refractive index.

Cell growth, protein induction and partitioning for dDHFR expression experiments.
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For all experiments involving partitioning of dDHFR, E. coli BL21(DE3) cells were
grown in LB medium until mid-log phase (OD600 = 0.6). Cells were induced with 1 mM
final IPTG concentration for 90 minutes. All growth and induction was performed at 37
°C. The cells were harvested after equalization for OD600 by centrifugation at 4,000 x g
for 2 minutes, the media was discarded, and the cells were lysed using BPER-II reagent
at room temperature for 10 minutes with 1µg/ml final DNase I added to the lysis mixture.
The sample was then centrifuged at 18,000 x g for 30 minutes to separate insoluble
(pellet) and soluble (supernatant) components. The samples were subsequently prepared
by boiling in SDS running buffer for running on 12% SDS-PAGE gels.

• TMP titration in E. coli cultures.
TMP was dissolved in 100% methanol and then diluted to the desired concentration in
media immediately after the addition of IPTG. Final methanol concentration did not
exceed 7% v/v at the end of the experiment. Cells were harvested and partitioned as
mentioned above.

• Chloramphenicol shut off experiments.
Protein was induced for 90 minutes in the presence of 80 µM TMP. A fraction of the cells
was harvested before any chloramphenicol was added and a second sample was collected
after an hour of incubation with chloramphenicol at a final concentration of 50 µg/ml.
The partitioning measurements were performed as described above. For the change of
media experiment, a fraction of cells was harvested after the 90 minute induction of
DHFR in the presence of 80 µM TMP. The remaining cells were centrifuged for 10
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minutes at 4000 x g, washed with equal volume LB, centrifuged again and resuspended in
LB supplemented with chloramphenicol at 50 µg/ml without any TMP. The second
sample was collected after an hour of incubation with chloramphenicol and processed as
described above.

• Mammalian cell growth, and experiments with α-galactosidase.
We seeded 10 cm culture dishes with HEK 293T cells and allowed them to reach ~80%
confluency at 37 °C, 5% CO2. We then transfected the cells with the R301Q α-GAL
pCMV 3xFLAG-14 (R301Q α-GAL) vector using Lipofectamine 2000. At 24 hours posttransfection we trypsinized the cells and used the resulting suspension to seed 6-well
plates for the DGJ titration experiment. The cells were allowed to adhere over a 4 hour
incubation period, after which desired amounts of 1-deoxygalactonojirimycin (DGJ) or
lactacystin (20 µM final concentration) were added. After 24 hours the cells were washed
thoroughly with PBS, then lysed with ice cold lysis buffer (1% Triton X-100 in PBS).
The lysate was centrifuged at 18,000 x g for 30 minutes and the soluble fraction was used
for analysis. The samples were normalized prior to loading using the biscinchoninic acid
(BCA) protein quantification method to ensure that equal amounts of protein were loaded
in each case. The western blot was performed using as primary a polyclonal rabbit
antibody against human α-GAL (purchased from GeneTex).

• Gel band quantification.
SDS-PAGE gels were stained with Coomassie G-250, scanned and analyzed on the LICOR ODYSSEY CLx and quantified using the associated image studio software (version
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4.0) (Luo et al., 2006). Western blots for the α-GAL experiments were similarly
analyzed.
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CHAPTER 3
INVESTIGATING THE IMPACT OF THE PROTEOSTASIS NETWORK ON
THE FODLIGN OF AN OBLIGATE CLIENT IN VIVO

This chapter describes my investigation of the folding, misfolding and aggregation
properties of an obligatory chaperone client protein inside the cell. Using a combinatorial
approach of computational modeling and experiments designed to test the impact of
chaperones on the folding of the client protein at varying expression levels we have
uncovered how such proteins fold in vivo. The work in this chapter was in collaboration
with Todd Morse, Ha Dang and Evan Powers

3.1. Chaperone assisted protein folding inside the cell
Besides aiding in stress responses, preventing protein aggregation and at times reversing
it, molecular chaperones often play a vital role in protein folding (Kim et al., 2013). An
important aspect of protein folding inside the cell is the dependence of certain proteins on
molecular chaperones to attain the native/folded state. This reliance on chaperones, which
involves a physical interaction with the chaperones steers the protein away from
deleterious aggregation states and towards a more productive native state. As one can
now imagine a kinetic competition for protein sequence (see Chapter 1), chaperones bias
the competition to favor the formation of the native state from the unfolded state (which
we consider the progenitor of all states inside the cell). In our model organism E. coli
there are two major chaperone families that can selectively favor folding over non68

productive outcomes such as degradation and aggregation. The first is the Hsp60 family
member GroEL and its co-chaperone GroES (Kerner et al., 2005; Kim et al., 2013). This
chaperone assembles in a tetradecameric ring creating a cavity that can be occupied by a
protein molecule undergoing the folding reaction. There remain many open-ended
questions pertaining to the molecular mechanism of the action of GroEL. For our
purposes we assume that GroEL is a channel that funnels proteins from the unfolded state
to the native state in any of the two predominant modes of its action (passive folding
cage/active substrate interaction leading to folding). The second set of chaperones is the
Hsp70 family, with DnaK as the E. coli member, which works with its associated cochaperones DnaJ and GrpE (Calloni et al., 2012; Kim et al., 2013). There is little direct
evidence that DnaK directly facilitates the formation of the native state from the unfolded
state, i.e. it does not directly affect the folding rate; rather DnaK seems to prevent
transitions into off-pathway misfolded states and provide an escape route from such a
misfolded state. This role contributes to an effective increase in the concentration of the
folded native product (Clerico et al., 2015). Proteomic analysis has yielded a list of ~250
proteins that can interact with GroEL, and of these 80 proteins in the E. coli proteome
which are unable to fold without the assistance of the GroELS chaperone system (Kerner
et al., 2005). Such proteins have been termed as class III or obligate GroEL substrates.
Furthermore, a depletion of GroELS from cells results in the accumulation of client
proteins on the DnaK chaperone (Kerner et al., 2005). These interesting observations lead
us to investigate the how these two major chaperone systems work together to achieve
folded protein in vivo. An interesting question arises from these observations: what are
the biophysical properties of the obligate chaperone-dependent client proteins?
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Specifically, what are the biophysical folding/misfolding properties of such client
proteins in terms of folding and unfolding rate and equilibrium constants, and how do
these constants compare with one another for an obligatory chaperone client?
Furthermore, can we estimate these properties from cellular experiments and observed
dependence on chaperones? This would be useful information, particularly considering
the fact that refolding these proteins in vitro without chaperone assistance is extremely
challenging. These questions are all part of understanding how the biophysical properties
of proteins interface with the proteostasis network inside the cell such that folding is
optimized and deleterious consequences such as aggregation are avoided.

3.2. What can we hypothesize about proteins that depend on chaperones in vivo?
Kinetic competition is a central theme underlying protein folding inside the cell. Once a
protein is synthesized, the intrinsic propensities to fold, misfold and aggregate will dictate
the trajectory of that protein inside the cell. One class of the major factors that influences
these trajectories are molecular chaperones and degradation enzymes (described above).
Using a computational model (FoldEco) developed by our lab in collaboration with Evan
Powers, we asked what types of proteins would be most aided by different classes of
molecular chaperones (Powers et al., 2012)? In this calculation, a test dataset of 4000
proteins of varying biophysical properties (within published limits) was created. In the
modeling these proteins were synthesized at various synthesis speeds using the FoldEco
program in the absence of any molecular chaperones. FoldEco tracks the time evolution
of pools of protein in different states of the protein including native, misfolded and
aggregated as well as chaperone-bound, and the program was used to generate the
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concentration of protein that aggregated at the end of the experiment. In a second
experiment with the same protein set, the molecular chaperones DnaK (the KJE system)
and GroEL (the ELS system) were reintroduced individually, and the fate of the
aggregated pool of proteins was similarly tracked. Based on these simulation
experiments, it was inferred that at slower synthesis rates the presence of DnaK lowered
the aggregation of those proteins that had a high propensity to misfold compared to the
average misfolding tendency of the set of proteins tested. Specifically the proteins most
helped by DnaK had a high km (misfolding rate constant). Similarly, the presence of
GroEL seemed to have its greatest effect on those proteins that folded much more slowly
than the average folding speed of the set of tested proteins. However, at faster synthesis
rates, the roles of GroEL and DnaK were seemingly very similar, and slow folding
proteins were aided by DnaK as well as GroEL, whereas proteins with a higher
propensity to misfold were also helped by both chaperone systems. Another experiment
from the same study, asked the question of how the presence of degradation machinery,
specifically the Lon protease affected the folding of proteins. Up-regulation of Lon, as
the study suggests and predicts had an impact on the total protein concentration, but had a
stronger impact on the misfolded species as it accumulated (Figure 3.1). Taken together,
these simulations suggest a synergistic action of the proteostasis components to shuttle
substrates from the unfolded (U) state to the native state while simultaneously lowering
the population of the protein that accumulates in the misfolded (M) state either by
prevention of the formation of the M state or by its degradation.
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Thus, we hypothesize that a protein that requires GroEL to fold successfully (a class III
substrate as classified by Kerner et al. (2005)) (Kerner et al., 2005), is a slow folding
protein, i.e. with a low kf (rate constant of folding). Based on how the protein aggregates,
one can then determine what the misfolding and aggregation rate constants would be
relative to the folding rate constants. Additionally, if one can introduce probes for the
unfolded state (such as GroEL) or for the misfolded state (such as Lon) or perhaps both
(such as DnaK) based on the hypotheses generated by the FoldEco simulations, one can
start to dissect the folding behavior of an obligate chaperone client inside the cell.

In experimental studies performed by Cho et al. (Cho et al., 2015) on studying the impact
of the proteostasis network on protein folding inside E. coli the FoldEco model was
useful to back calculate some of the biophysical parameters of the proteins in the study.
And while that study was informative in terms of how chaperone systems can work
together to benefit folding, it did not address the folding behavior of a naturally occurring
protein that has co-evolved over millennia with cellular chaperones and to fold under
their influence.
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Figure 3.1 Hypotheses for chaperone functions based on computational modeling
A. Based on the FoldEco simulation study with 4000 proteins with a distribution of
folding, misfolding and aggregation rate constants, at slower synthesis rate proteins with
high misfolding were prevented from aggregation by the KJE system, similarly slow
folding proteins were helped by GroELS.
B. At increased synthesis rate the effects of the GroELS and DnaK were seen on proteins
with similar properties of folding and misfolding. Both GroEL and DnaK reduced the
aggregation of those proteins with low folding rate constants and had a higher than
average misfolding propensity.
C. Lon has ability to suppress aggregates by reducing protein concentration. The
concentration of protein reduced by lon depends on the presence of the other chaperones
that can act to sequester the protein away from. Figure adapted from Powers et al (Powers
et al., 2012).
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3.3. Choosing an experimental system
We chose to work in E. coli BL21(DE3) for experimental tractability and the fact that it
lacks the Lon protease allowing us to study chaperone dependence in a background
without proteolysis (which for FoldEco we assume is performed by Lon). In our lab, we
have methods to upregulate individual chaperone components by mean of a plasmid
provided in trans to the genetic copy of the chaperone or the degradation enzyme lon
(BL21(DE3) lacks a functional Lon protease thus making it easier to determine the
effects of varying concentrations of Lon on the substrate in the presence of other
chaperones). Much of the power of FoldEco also comes from the biochemical
investigations that have been carried out over the past several years on the chaperone
systems of this organism. As there are only two major chaperone systems, GroEL and
DnaK, we do not have to worry about redundant versions of the chaperone systems
playing a major role in the folding of our test protein.

For our test protein we chose a native E. coli protein S-adenosylmethionine synthase
(gene name metK). MetK is an enzyme with a transferase function (E.C. 2.5.1.6)
(UniProt, 2015). Specifically it catalyzes the formation of S-adenosyl methionine using
ATP and Methionine as substrates. MetK is a cytosolic, soluble 384 amino acid protein
with a monomeric molecular weight of ~42 kDa. MetK assembles into homotetramers as
a final quarternary structure (Figure 3.2) (Komoto et al., 2004). MetK has been shown to

76

be a class III GroEL substrate. In in vitro refolding studies by the Hartl lab (Kerner et al.,
2005), MetK is unable to fold and function when introduced into refolding conditions in
the absence of the GroELS system. Refolding in the presence of GroELS alone restores
MetK activity to ~70% of native MetK whereas refolding in the presence of DnaKJE and
GroELS restores up to 90% activity of the protein. Refolding in the presence of the KJE
system alone, however, does not restore any measurable activity. These in vitro tests
indicate that MetK obligatorily requires an interaction with GroEL to reach the native
state. MetK on a pET 29b plasmid was kindly provided to us by the Hartl laboratory
(Max Planck Institute, Martinsried Germany) and the proteostasis components were
available on arabinose inducible pBAD plasmids that were provided from previous
FoldEco studies conducted jointly with the Kelly/Powers laboratories (Cho et al., 2015;
Kerner et al., 2005).
Figure 3.2 Model test protein MetK
A. The choice of test protein is MetK (PDB 1RG9), monomer and tetramer shown above.
MetK is a homotetramer and GroEL catalyzes the folding of this protein. For our
experimental consideration, we treat the species subject to proteostasis treatment to be the
monomer.
B. The above cartoon shows the reaction catalyzed by MetK. The enzyme is essential in
E. coli and is responsible for the biosynthesis of S-Adenosyl methionine.
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3.4. MetK – Equilibrium folding properties of MetK
To understand the folding properties of MetK, i.e. the folding rate constant, unfolding
rate constant, misfolding rate constant and the aggregation rate constant in the cellular
context we need to first dissect the contribution of tetramerization to the folding fate of
MetK. Tetramerization can be regarded as self-liganding mechanism for MetK as is seen
in the case for transthyretin and other multimeric enzymes. To determine the
tetramerization dissociation equilibrium constant, we performed equilibrium denaturation
experiments with guanidine hydrochloride as a function of MetK concentration. MetK
denaturation shows a three-state equilibrium unfolding curve and the midpoint of the first
transition shows a concentration dependent sensitivity to guanidine induced denaturation,
whereas the midpoint of the second transition is insensitive to MetK concentration at
higher guanidine concentrations. This observation is consistent a dissociation of the
tetramer at low guanidine concentrations causes while the denaturation of the monomer
occurs at higher concentrations of the chaotrope. By performing guanidine denaturation
experiments as a function of MetK concentration we were able to determine two
equilibrium parameters for MetK. The first was the limiting tetramerization
concentration. This was determined as the concentration of MetK at which the first
transition was no longer seen in the guanidine denaturation experiment. The second
parameter was the apparent unfolding equilibrium constant, which would theoretically be
the ratio of the unfolding to folding rate constants. This number could serve as a guide to
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help fit some of the MetK rate constants using FoldEco. From our experiments, the
limiting tetramerization concentration was ~0.13 µM as at that concentration the first
transition was not seen for MetK denaturation (Figure 3.3A). This suggests that even at
low concentrations, MetK readily forms the tetramer and once it is in the tetrameric state,
it can be assumed to be resistant to aggregation that would initiate as consequence of
tetramer dissociation and unfolding (see chapter 2 for how ligands prevent aggregation).
The second equilibrium constant we obtained was the apparent unfolding equilibrium
constant which was 9 x 103, indicating that the monomer of MetK was stable as the
folded species outnumbered the unfolded species by roughly 10000 molecules to 1
(Figure 3.3B). It is important to note here that the unfolding equilibrium constant is an
apparent constant, since the reaction is not reversible. Effectively, folding does not occur
without GroEL assistance.
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Figure 3.3 Equilibrium denaturation properties of MetK
A. The family of curves depicts MetK denaturation over a range of concentrations (brown
– 0.136, red – 0.272, green – 0.408, blue – 0.572 and pink – 1 µM concentration of
tetrameric protein respectively). One can observe two transition points, one under 1M
wher Cm changes with MetK concentration and 1 at approximately 2.5 M where Cm does
not change. The first transition which represents tetramer dissociation disappears at 0.13
uM thus allowing us to determine the equilibrium constant for tetramer dissociation.
B. Denaturation of monomeric MetK. This set of points is derived from the full
denaturation, this transition does not change with MetK concentration, The equilibrium
unfolding constant for the monomer (Ku) was calculated to be – 9 x 103 .by fitting the data
to the two-state equation to estimate folding free energy (Bolen and Santoro, 1988).
C. Model for equilibrium MetK unfolding. We propose a model for MetK denaturation
where dissociation of the tetramer is the first step and it is limited by the concentration of
MetK and the second step is the denaturation of the monomer. Monomer denaturation is
shown irreversibly as the protein depends on GroEL to get to the folded state.
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3.5. MetK overexpression and aggregation at “basal” proteostasis levels.
To determine the nature of the competition between folding and aggregation, we
overexpressed MetK in E. coli BL21(DE3) cells. We examined the folding fates of MetK
by quantifying the total amount of MetK synthesized and then interrogating what fraction
of the protein produced became insoluble after our synthesis time. It is important to note
here that as there is no degradation component yet, MetK has two possible folding fates;
either it folds correctly (with the help of GroEL) or it misfolds, self-associates and
aggregates, which is to say it escapes any positive interaction with GroEL and has
misinteractions with other MetK molecules. We use solubility or insolubility after
expression as a readout after protein synthesis to determine where MetK partitioned after
production. We assume that soluble MetK is well folded, but the soluble MetK could be a
mixture of well folded, chaperone bound or a ligand bound (MetK binds ATP,
methionine and the product S-adenosyl methionine) species, a partition that presently
evades separation. However, the insoluble MetK is obtained from inclusion bodies, which
contain the misfolded MetK that aggregates inside the cell after synthesis. Thus we use
the aggregated fraction (Fagg or Fractionaggregated), defined as the ratio of the intensity of
the aggregated fraction to the intensity of the total protein synthesized as our readout for
the folding of MetK (see equations below). The intensity of the total and aggregated
fraction was calculated after running the samples on a 12% SDS-PAGE gel and staining
with Coomassie G-250 stain. Stained gels were imaged using the LI-COR system and
were analyzed using the associated gel analysis software.
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[MetK ]Total = [MetK ]sol +[MetK ]insol
Fractionaggregated =

[MetK ]insol
[MetK ]total

As mentioned earlier, the MetK gene was subcloned into a pET29b vector, with protein
expression driven from an isopropyl β-D-1-thiogalactopyranoside
(IPTG) inducible T7 promoter. To investigate the folding-aggregation competition of
MetK, we varied its concentrations inside the cell by titrating increasing amounts of
IPTG (from 1 µM to 200 µM final concentrations) into cells grown to mid-log phase
(OD600 ~ 0.6). By comparing total cell lysates to purified MetK standards, we were able
to calculate the amount of MetK synthesized at each concentration of IPTG. We observed
that the MetK concentration ranged from 170 µM to approximately 2000 µM over the
range of IPTG concentrations we used. We also observed that protein concentration
peaked at ~2000 µM and did not rise further with increase in concentration of IPTG
(Figure 3.4A). The concentrations reported are MetK monomer concentrations and not
the tetramer. For our experiments we assume that the monomer is the species acted upon
by the cellular proteostasis network. We then calculated the concentrations of the
chaperones DnaK and GroEL present at our growth conditions, again by comparison with
standard purified amounts loaded on SDS-PAGE gels. The aggregated fraction of MetK
was measured after harvesting cells at the end of the protein induction time, followed by
cell lysis by sonication and separation of soluble and insoluble components by high-speed
centrifugation. The aggregated fraction of MetK increased with an increase in the
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concentration of MetK synthesized (not surprisingly, as aggregation is concentration
dependent). The fraction aggregated (measured from 0 to 1) rose from an average of 0.2
at an intracellular concentration of MetK of 170 µM MetK to an average of 0.45 at
approximate [MetK] of 2000 µM (Figures 3.4 A, B). For these experiments performed at
what we term “basal” levels (no chaperone overexpression), the concentrations of GroEL
(as an active tetradecamer) and DnaK were calculated to be 130 and 70 µM on average
Figures 3.8A, B see pages 120-123).

Figure 3.4 Synthesis and aggregation of MetK at basal chaperone conditions
A. The above figure shows the concentration of MetK synthesized at varying IPTG levels
under “basal” levels of chaperones. MetK levels rise with IPTG concentration until
200uM, then plateau. The concentration in cell measured by comparison with purified
standards.
B. Fagg of MetK as a function of concentration. MetK Fagg increases with increase in
concentration from 0.25 to 0.47 under “basal” chaperone conditions. Due to a limitation
of MetK synthesized the aggregated fraction does not rise further.
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Our observations with MetK folding/aggregation at these basal chaperone conditions
allow us to draw some important conclusions. First, even at nearly stoichiometric
amounts of MetK to GroEL (at low concentrations), MetK aggregates inside the cell.
This suggests that the intrinsic propensity of MetK to aggregate is higher than the
association rate with GroEL (and perhaps even the equilibrium association with GroEL).
Thus if we were to now begin to compare the folding and misfolding rate constants for
MetK (which we suggest are the major drivers for the distribution of MetK), at a first
approximation the ratio of the misfolding/aggregation rate constants to the folding rate
constant is larger than 1 (As km, kagg > kf). The next set of experiments involves the
overexpression of either the GroELS system or the DnaKJE system or the Lon protease to
determine how the fluxes between folding and aggregation change when you have
mechanisms to selectively target one or more states. Knowledge of its folding outcomes
in the presence of lon and the DnaKJE system would refine our understanding how the
other biophysical parameters – misfolding and aggregation would be compared to the
folding parameters – we plan to bolster our experimental findings with computational
modeling to achieve a more quantitative understanding of the system. Furthermore, these
experimental readouts can then be used as inputs for FoldEco simulations to predict what
the biophysical parameters for MetK might be inside the cell.
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3.6. Effect of GroELS titration on MetK aggregation
(These experiments were performed in collaboration with Ha Van Dang – Mount
Holyoke College)
Since GroEL serves as a conduit that funnels MetK from the unfolded state to the folded
state, we hypothesized that increasing the concentration of GroELS would enhance the
efficiency of MetK folding and lead to a diminution of the aggregated MetK population .
We co-transformed E. coli BL21(DE3) cells with the MetK plasmid and a GroELS
plasmid, with the expression of GroELS driven by an arabinose inducible promoter and
that of MetK by an IPTG inducible T7 promoter. GroELS was titrated to varying
concentrations using concentrations of arabinose from 0.002 to 0.2% (w/v final
concentration) (Figure 3.8A). The range of [arabinose] used allowed us to test [GroEL]
from the basal level of ~130 µM to as high as approximately 1600 µM. For these
experiments, we first grew the co-transformed cells to an OD600 of 0.3 at which point we
induced GroELS with the desired amount of arabinose. After 1 generation of growth at
OD600 of 0.6 we induced MetK with varying IPTG concentrations. Determination of total
MetK and fraction MetK aggregated was performed similarly.

We made two major observations regarding MetK synthesis and aggregation with the
GroEL titration experiment. First, as GroELS intracellular concentrations increased, the
aggregation of MetK decreased. This result is not surprising as MetK is an obligate
GroEL substrate. It is important to note here that at no point is the aggregation of MetK
completely abolished. There appears to be a limit of about 0.15 fraction MetK aggregated
regardless of the concentration of GroELS (Figure 3.5A). At basal concentrations of
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GroELS (~130 µM), MetK synthesized at about 2000 µM has an average fraction
aggregated of ~0.45. However, at the same concentration of MetK, the higher level of
GroELS (~1600 µM) reduces the fraction aggregated to ~0.2. The observation that MetK
aggregation is not entirely abolished even at high GroELS levels (MetK ~ 170 µM,
GroEL ~ 1600 µM) allows us to suggest that the intrinsic misfolding rate of MetK (km) is
larger than the association rate constant between MetK and GroEL (and thus the rate
constant of GroEL mediated folding) (Figure 3.5C). This lower limit on aggregation is
similar to the one observed for dDHFR observed in Chapter 2 and also suggests a
chaperoning limit akin to the limit of the small molecule ligand which depends on the
intrinsic ratio of the folding to aggregation rate constants (kf/kagg)

The second observation was the fluctuation of MetK concentration at high levels of
expression of GroELS. While the concentrations of MetK remained relatively unchanged
at higher levels of MetK induction (in the presence of all concentrations of GroEL
induced), we observed a reduction of the concentration of MetK synthesized at lower
levels of induction (at lower IPTG concentrations). Generally we observed a reduction in
MetK synthesis at low levels of IPTG (particularly 5 and 10 µM, which under basal
conditions yields three-fold more MetK) and high levels of arabinose (at 0.02 and 0.2%
w/v where we achieve a GroEL concentration roughly 9 to 12 times of our basal level)
(Figure 3.5B). This observation indicates that there is a competition for protein synthesis
machinery, and that though we used orthogonal promoters to induce MetK and GroEL,
the protein synthesis outcome depends on the partitioning of the protein production
resources inside the cell. Interestingly, although not pursued, is the debunking of the
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notion that an IPTG inducible T7 promoter essentially overrides the protein synthesis
system preventing the translation of other proteins. This example of MetK – GroEL
(recollect that GroEL is induced with arabinose before MetK induction with IPTG) is a
good demonstration that the T7 driven expression can be affected by the production of
protein driven by an alternative promoter.
Figure 3.5 Impact of GroEL expression on MetK synthesis and aggregation.
A. The SDS PAGE gels show that higher GroEL concentrations lower the aggregation of
MetK at equivalent MetK concentrations (synthesized with 50µM IPTG). The Fagg never
reaches zero even at sub-stoichiometric amounts of MetK compared to GroEL indicating
a propensity to aggregate faster than association with GroEL.
B. GroEL induction at high levels causes diminution of MetK levels when MetK is
induced with low concentrations of ITPG likely due to competition for protein synthesis
machinery. C – trends observed for MetK aggregation as a function of GroEL and MetK
concentrations at the GroEL concentration Data and figures courtesy Ha Van Dang.
C. The chart shows the concentration of MetK and the fraction aggregated at different
average GroEL levels (top left corner – indicated by colours from red to blue). MetK
aggregation generally reduces with increasing GroEL concentrations, however there is no
concentration of GroEL at which MetK aggregation is entirely abolished. The error bars
represent an SEM of three experiments.
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3.7. Effect of DnaKJE on MetK aggregation
From the GroELS titration and the MetK aggregation at stoichiometric and higher
amounts of GroELS, it is clear that MetK has an intrinsic tendency to populate an offpathway aggregation-prone misfolded state faster than it can encounter GroEL. This
indicates that MetK populates the unfolded state (the precursor of all states), which
partitions into the misfolded state (the same one that arises from the unfolded progenitor
pool) and the state that binds GroEL. Based on the hypothesis presented earlier, the
presence of DnaK should aid in the correct folding (and thus lower the aggregation) of
proteins with a higher propensity to misfold. Experimental data from the Hartl lab
(Calloni et al., 2012) also suggests that GroEL substrates accumulate on DnaK upon
depletion of GroELS inside the cell. This too indicates a synergistic tendency of DnaK to
bind unfolded or misfolded proteins and prevent aggregation. Similar to the above
experiments with GroELS, we co-transformed E. coli BL21(DE3) cells with the MetK
plasmid and the plasmid containing genes for DnaK, DnaJ and GrpE. Also similar to
GroELS, the expression of the components of the KJE system was driven by arabinose.
The KJE components and MetK were induced by IPTG, similar to the protocol used for
the GroELS and MetK experiments.

Mimicking the observation in the GroEL induction experiments, the biosynthesis of
MetK showed a diminution at high concentrations of arabinose and low concentrations of
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IPTG, although the reduction in MetK synthesis was not as drastic as the one observed
with the GroEL experiment. By varying the concentration of arabinose (from 0.002 to
0.2% w/v final concentration), we could increase the concentration of DnaK from ~70
µM at basal (no addition of arabinose) level to ~700 µM (approximately 10-fold higher)
at the highest concentration of arabinose (0.2% w/v) used (Figure 3.8B). Over the range
of DnaK concentrations we tested, we observed a general decrease in the fraction of
MetK aggregated across nearly all MetK concentrations (Figure 3.6C). The decrease in
MetK aggregation also scaled with the increase in the concentration of DnaK, i.e. as we
synthesized more DnaK inside the cell, we observed a reduction in the aggregated
fraction at almost all concentrations of MetK produced, and this aggregated fraction
further diminished as DnaK concentrations rose (compare Figure 3.6A and B, compare
across concentrations of MetK and DnaK where DnaK concentrations increase from Blue
to Red and the MetK concentrations are represented on the X axis). The aggregated
fraction at lower levels of expression of MetK (170 µM) reduced from ~0.25 to ~0.1 at
the highest concentration of DnaK produced inside the cell. Similarly, the fraction MetK
aggregated when approximately 1500 µM was synthesized also reduced from an average
of 0.35 to 0.15. It was only at the highest levels of MetK synthesis that the aggregated
fraction of MetK was not reduced to a large extent (last concentration point shown in
Figure 3.6B, all colors). What does this tell us about the impact of DnaK on the folding of
MetK? First, as we know that MetK folds in a GroEL-dependent manner, it is not the
overexpression of DnaK that aids the folding reaction directly. However, given enough
DnaK, the cellular pools of GroELS (which did not appear to increase during these
experiments) become sufficient to achieve a high proportion of folded MetK. This
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suggests co-operation between the DnaK and GroELS chaperones. It appears that DnaK
can form a complex with MetK to protect it from aggregation, and then that DnaK
releases MetK in a form that is ushered by GroEL to the folded state. It should also be
noted that at no concentration of DnaK was the aggregation of MetK (at any
concentration) entirely abolished. All these observations are consistent with the
hypothesis that proteins with a high propensity to misfold are aided by the KJE system to
avoid aggregated states, and importantly this role of DnaK can work in concert with the
action of the GroELS system for proteins that are obligate GroEL substrates.
Figure 3.6 Impact of DnaKJE on the folding and aggregation of MetK.
A. DnaK at high levels ~ 650 uM strongly inhibits MetK aggregation as seen by the low
intensity aggregation bands at nearly all MetK concentrations on the SDS PAGE gel.
B. Similar to GroEL, as DnaK concentration increases (top right corner shows the
average DnaK concentration at the levels of MetK synthesized) the MetK aggregate
fraction reduces, yet never going to 0. DnaK helps prevent aggregation and allows what
little GroEL (estimated at 130 µM average) is present inside the cell to successfully fold a
large concentration of MetK.
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3.8. Effect of Lon titration on MetK aggregation in basal levels of KJE and GroELS
In addition to the folding limb of the proteostasis network, the other component of
protein quality control that keeps aggregation under check is the degradation machinery.
For proteostasis in E. coli the degradation machinery proposed to do this function is the
Lon protease. Experimental and modeling results suggest that while Lon decreases the
total concentration of a protein, this also causes a reduction in the amount of protein that
aggregates. There are two species that are believed to be degraded by the Lon protease
are the unfolded and misfolded state (Gur and Sauer, 2008; Gur et al., 2012; Powers et
al., 2012). Modeling of the fraction degraded and fraction aggregated data of the model
proteins used by Cho et al. (Cho et al., 2015) suggests that Lon targets either the unfolded
state or the misfolded state depending on how much the protein substrate intrinsically
populates the off-pathway misfolded state. For the DHFR mutant used in that study, the
effect of the Lon protease was on the unfolded state whereas the effect for the mutant
Cellular Retinoic Acid Binding Protein I (CRABPI) Y133S was on the misfolded state.
BL21(DE3) has no functional Lon protease. Up to now, all our investigations were in the
absence of any degradation caused by the Lon protease. Thus, re-introduction of Lon at
varying concentrations allowed us to directly test the effect of the protease in the
background of basal GroEL and DnaK conditions. Similar to the protocol used with the
GroELS and DnaKJE systems, the E. coli Lon gene was cloned into a plasmid where its
expression is controlled by arabinose. The experiments with Lon induction and protein
partition were performed similarly to the GroELS and DnaKJE experiments.
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Lon concentrations increased with increasing arabinose concentrations added to the cells.
The concentrations rose from ~3 µM hexameric (the active state is a hexamer) Lon at an
arabinose concentration of 0.002% final w/v to an average of 23 µM Lon at the highest
concentration (0.2% w/v final) used (Figure 3.8C). Over the range of Lon concentrations
tested, MetK concentrations at all levels of IPTG were depleted relative to that in the
absence of Lon (Figures 3.7A, B). For example, the final concentration of MetK for the
same addition of IPTG was reduced by half when Lon was present at 23 µM (compare
blue and red points in Figure 3.7C). Furthermore, the aggregated fraction was also
diminished at higher Lon concentrations. This is not a novel observation as a reduction in
protein concentration diminishes the concentration of the aggregation prone species.
However, we clearly observed that at nearly equal concentrations of MetK (see data
points between 600 and 1100 µM MetK), an increase in Lon concentration reduces a
larger amount of the aggregated protein (Figure 3.7C). This is indicative of a mechanism
where Lon facilitates the clearance of a species en route to aggregation. For MetK, it
appears that the presence of Lon has an impact on the misfolded species as it selectively
reduces the aggregated fraction within the total protein population. This observation is
consistent with the hypothesis that Lon degrades off-pathway misfolded proteins (Powers
et al., 2012). Also consistent with the impact on Lon in BL21(DE3) cells, cells expressing
a high concentration of Lon also grew more slowly than cells with little or no Lon
present. This is likely due to the degradation of the yoeB antitoxin which is the cognate
antitoxin in the yefM – yoeB toxin – antitoxin pair, which has been implicated in biofilm
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formation and regulation of its own gene products via transcriptional attenuation
(Christensen et al., 2004).
Figure 3.7 Impact of lon on MetK synthesis and aggregation.
A. The SDS PAGE gesl shows the impact lon at medium levels ~ 17 uM. This
concentration of lon reduces concentration of MetK synthesized at the same
concentration of IPTG added under the basal conditions (compare with Figure 3.4). It
also reduces the aggregated fraction, not surprising as total levels of MetK are lowered.
B. Increase in lon concentrations (from Blue to Red, top right corner shows average
values) lowers MetK synthesized proportionally with the lon synthesized. Similar
concentrations of MetK between (700 – 1100 uM MetK) show altered aggregated
fraction and higher the lon levels, lower the Fagg at these concentrations. This indicates
that lon degrades an aggregation prone, off-pathway misfolded state.
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Figure 3.8 Concentrations of chaperones produced as a function of arabinose
concentrations.
A. GroEL synthesized during the GroELS titration experiments is measured by
comparison against purified GroEL.
B. Similarly DnaK synthesized at the various DnaKJE titration experiments is measured
by comparison with purified proteins.
C. Lon concentrations are also measured by comparison with purified standards. Purified
GroEL, DnaK and lon were gifts from Ivan Budyak, Joseph Tilitsky and Rilee Zeinert
respectively.
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3.9. Modeling the data with FoldEco
(The mathematical modeling was performed by Evan Powers)
To understand the folding behavior of MetK inside the cell, we used FoldEco to fit our
experimental data. The major parameters in FoldEco that can be manipulated are the
equilibrium constants and kinetic rate constants for the folding, misfolding and
aggregation reactions. The FoldEco simulation was performed iteratively to match the
experimental dataset. The best fit between the FoldEco simulation and the experimental
data showed a root mean squared deviation of 0.13 and allowed us to infer three
important conclusions. The first, is that the ratio misfolding rate constant to the folding
rate constant (km/kf) is 2 which is in good agreement with our hypothesis from section 3.5
where we state km is larger than kf. Specifically the FoldEco fitting allows us to
approximate the values of km and kf to 0.02/s-1 and 0.01/s-1 respectively. These values are
also in good accord with the predictions made by FoldEco about proteins that rely on the
GroELS system (and MetK is an obligate substrate). The second conclusion is that
aggregation is almost instantaneous after accumulation of the misfolded state suggesting
a low life time for this off-pathway state. Third, the fit also does not converge well on the
equilibrium constants again suggesting that the partitioning of MetK inside the cell is
under kinetic control rather than thermodynamic control. In Figure 3.9 we see a general
schematic for the kinetic partitioning for MetK and using this model (that is essentially
how FoldEco describes the kinetic partitioning of proteins) we can now being to see how
the folding and misfolding reactions compete with each other in the presence of
chaperones and how chaperones change the folding outcome even when the misfolding
rate constant is larger than the folding rate constant.
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Figure 3.9 The kinetic partitioning of MetK upon synthesis in E. coli
The figure below shows the general kinetic partitioning scheme for MetK. S, U, N, D, A
and M represent the synthesized, unfolded, native, degraded, aggregated and misfolded
populations of MetK. The rate constants for the individual reactions is denoted by kreaction.
Folded MetK is represented as a monomer (Nmono) or a tetramer (Ntetramer). GroEL
catalyzes the transition from U to N. DnaK is shown to interact with either the U or the M
state whereas lon is shown to degrade either the U or M state. The aggregates are shown
as inclusion bodies which is how proteins aggregate in E. coli.
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3.10. Conclusions
Our experiments provide insight into the species populated by MetK upon synthesis in E.
coli. Consistent with hypotheses generated by FoldEco, MetK is a slow folding protein
that tends to populate the off-pathway misfolded state with a larger than average (with
respect to the average properties of the 4000 test proteins used in the computational
study) (Powers et al., 2012) propensity. This misfolded population is hypothetically a
target for the Lon protease, and our results support this hypothesis in that we observed a
greater diminution in the fraction aggregated than the total protein at similar
concentrations of MetK as Lon concentration increased. The propensity of MetK to
aggregate even at larger than stoichiometric concentrations of both GroEL and DnaK
indicates that MetK has an intrinsic aggregation rate faster than a GroEL facilitated (as
without GroEL the rate is not readily observable in reasonable time scales) folding rate.
Furthermore, we have inferred a chaperone cooperation wherein DnaK is able to prevent
the aggregation of MetK and subsequently co-ordinate with GroEL to ensure the
successful folding of a large population of the protein.

While the folding of MetK is stringently dependent on GroEL in E. coli, it is interesting
to note that organisms lacking GroEL such as Mycoplasma synoviae have MetK
homologs (Georgescauld et al., 2014). The M. synoviae MetK shares approximately 47%
percent sequence identity with the E. coli MetK. On imposing the similar residues on to
the structure of the E. coli MetK, we observed that the similar residues were concentrated
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at the interface of the MetK dimer (Figure 3.10). This provides a hypothesis that the
assembly of MetK might be conserved evolutionarily, whereas the folding of the
monomeric protein has co-evolved with the organismal proteostasis network (or lack
thereof).
Figure 3.10 MetK assembly might be independent of monomer folding.
A. The image shows the dimer of E. coli MetK (PDB 1RG9) with one chain shown in
spheres and the other as a cartoon. Comparing the sequences of homologous MetK, one
from E. coli and another from an organism that lacks GroEL (M. synoviae), it is apparent
that identical residues (coloured red) are clustered in the dimer interface whereas nonidentical residues (coloured green) are distal to the dimer interface. This figure looks at
the dimer interface through one of the monomers (blue cartoon).
B. This cartoon shows the MetK dimer interface from the side where the residues
identical between E. coli and M. synoviae are easier to visualize. This conservation
pattern can be used to hypothesize that MetK assembly might be evolutionary conserved
but the folding of the monomer has co-evolved with the chaperone in the case of E. coli.
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Lastly, as seen in the section of how DnaKJE help out MetK under limiting
concentrations of GroEL, it has not escaped our attention that in this scenario, DnaK is
able to compensate for the action of GroEL at most concentrations of expressed MetK.
There could be two ways DnaK could exert its effect, the first being serving as a holding
point for freshly synthesized MetK and keeping it from aggregation. In this scenario, the
synthesized MetK would partition simultaneously to both DnaK and GroEL but as the
concentration of MetK exceeds the concentration of GroEL the remainder of the protein
would partition to the excess DnaK and finally the protein population that escapes both
chaperone systems will aggregate. In this scenario, DnaK would hold on to the MetK
polypeptide and release it in a manner capable of being acted upon by GroELS. The
release of MetK and the processing by GroEL (which is necessary for MetK folding)
appears to have some stoichiometric balance at lower levels of MetK as the limiting
GroEL is able to handle that protein load in the presence of high concentrations of DnaK.
The second model invokes the possibility that DnaK sequesters other GroEL client
proteins and thus increases the capacity of GroEL to accommodate larger concentrations
of the synthesized MetK. However, this model may not hold as most of the cellular
protein synthesis machinery is occupied for the synthesis of the chaperone components
(induced by arabinose) or for the synthesis of MetK (under IPTG control). Thus most of
the protein synthesized will likely be MetK and thus reduces the chances (essentially
outcompetes) of any other protein substrate to be bound by DnaK.

3.11. Materials and methods
• Cloning, expression and cell culture:
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The MetK gene on a subcloned into a pET29b+ vector (Kanamycinr, IPTG inducible)
was a gift from the Hartl laboratory (Max Planck Institute, Martinsried Germany).
DNAKJE and lon genes were subcloned into the pBAD33 vector (Chloramphenicolr,
arabinose inducible) and were the same as the constructs used in Cho et al. (FoldEco
2015). Similarly the pGro7 was also the same construct used in Cho et al. with GroELS
synthesis driven by arabinose. The chaperone plasmids were a gift from the Kelly
laboratory (The Scripps Research Institute, La Jolla USA).
BL21(DE3) E. coli cells (Invitrogen) were transformed with either the MetK or the MetK
and one of any three of the chaperone plasmids mentioned above. The cells were plated
on Luria Bertani (LB) agar containing Kanamycin and Chloramphenicol at a final
concentration of 50 µg/ml and 34 µg/ml respectively. Cultures for the induction and
partition experiments were started from overnight cultures initiated from a single colony
of the transformed E. coli. For induction of proteins, the transformed cells were grown in
LB medium at 37 o C until they reached an OD600 of 0.3 at which point the chaperone
components were induced with the desired concentration of arabinose (range between
0.002% and 0.2% w/v final concentration). Cells were then allowed to grow till an OD600
of 0.6 (after ~30 minutes) at which point MetK was induced using a desired
concentration of IPTG (range between 1 and 1500 µM final concentration). Cells were
harvested by centrifugation at 4000 x g for 2 minutes after 1.5 hours of MetK induction
after normalizing OD600 to 1 across samples.

• Partition experiments and concentration measurement
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Harvested cells were resuspended in 20mM Tris at pH 7.4 and were lysed using a
sonicator. Sonicated cells were then centrifuged at 18,000 x g for 30 minutes to separate
the soluble and insoluble components. The total (unlysed), the supernatant and the
insoluble component (after resuspension in equal volume buffer prior to cell lysis) were
then run on 12% SDS PAGE gels. The gels were stained with coomassie brilliant blue G250 dye and scanned on the LICOR gel documentation system after destaining.
Quantification of the gel band intensity was carried out using the Odessy 4.0 software
associated with the LICOR. To measure concentration of protein, known concentrations
of purified protein (MetK, GroEL, DnaK or lon) were loaded on the same gels as the
unknown sample. Comparison of the unknown to the standard curve generated from the
purified protein yielded the concentration of protein (µG) present in the sample loaded on
the gel. By accounting for the number of cells used for the experiment we estimated the
cytosolic volume (Volkmer and Heinemann, 2011) and used that to measure the
concentration (µM) of the protein inside the cell. Purified chaperone components GroEL,
DnaK and Lon were kindly provided by Ivan Budyak, Joseph Tilitsky and Rilee Zeinert
respectively.

• Purification of MetK
Cell growth and protein induction.
MetK (pET 29b) was transformed into E. coli BL21(DE3) cells and a single colony was
used to start an overnight culture. 1.5% of the overnight culture was used to start a fresh 1
L LB + Kanamycin (final 50ug/ml) culture. The 1 L culture was grown to OD 600 of 0.6
at which point it was induced with a final IPTG concentration of 0.2mM for 4-5 hours.
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All growth and induction was done at 37 o C. Cells were harvested by centrifugation at
4000 x g and resuspended in 20mM HEPES pH7.4 and flash frozen with liquid N2 until
further use.

• Cell lysis.
Frozen cells were thawed under running cold water until completely thawed and then
were lysed using the microfluidizer. After being microfluidized, the lysed cells were
centrifuged at 20,000 rpm for 30 minutes and the insoluble fraction was discarded. The
soluble fraction was processed further.

• Ammonium Sulphate precipitation.
The first step was to perform an ammonium sulphate precipitation of the protein and or
contaminants. Solid ammonium sulphate was gradually added to the supernatant after cell
lysis in 10% increments with slow stirring in 10 minute intervals. At 60% ammonium
sulphate, the protein (soluble MetK) was mostly in the precipitate.

The 60% ammonium sulphate precipitate was resuspended in 20mM HEPES at pH 7.4
and dialyzed against 20mM HEPES at pH 7.4 to remove as much ammonium Sulphate as
possible before further treatment.

• Hydroxyapatite column chromatography.
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The dialysate from the ammonium Sulphate precipitation was loaded a pre-equilibrated
hydroxyapatite column (pre equilibrated with 10mM Sodium Phosphate monobasicdibasic buffer at pH 6.8. MetK binds both ATP and L-met and hydroxyapatite is a
chemical mimic of ATP. The protein was loaded on the column and washed with 20mM
sodium phosphate (monobasic - dibasic component buffer at pH 6.8) and eluted with a
gradient ranging from 20mM to 300mM of the same buffer.

MetK eluted in the wash, which was at low concentration of sodium phosphate and the
impurities eluted at higher concentrations of the elution buffer. The sample was then
dialyzed against 20mM Tris pH 7.4 and flash frozen and stored at -80 o C till further use.
The concentration was determined by sending out pure protein for amino acid analysis at
the Texas A and M university protein chemistry laboratory

• Equilibrium denaturation experiments
MetK at fixed concentration was diluted into a range of guanidine hydrochloride
concentration and incubated over 12 hours at 37 o C to ensure unfolding. The unfolding
of MetK as a function of guanidine hydrochloride was followed by collecting tryptophan
emission spectra between 320 and 380 nm after excitation at 295 nm. Plotting the
maximum wavelength as a function of guanidine chloride calculation yielded a three state
equilibrium denaturation curve. Repeating the experiments over a range of MetK
concentrations revealed the first transition sensitive to guanidine concentration and the
second transition somewhat insensitive to MetK concentration. Fitting the second
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transition to a two state equation yielded an apparent thermodynamic stability for the
MetK monomer (Pace 1986).

Data for MetK concentration, fraction aggregated and concentration of chaperones at
various IPTG and arabinose concentrations is listed in the appendix section of the
document.
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CHAPTER 4
MUTUALLY EXCLUSIVE FOLDING – SENSORS FOR PROTEIN
STABILITY

This chapter investigates how we can utilize a fusion protein system that relies on ligand
binding to test the thermodynamic stability of a protein of choice inside the cell. This
study attempts to bring together the concept of how ligand binding (explored in Chapter
2) can be potentially harnessed to alter the stability of a protein connected distally to the
ligand binding protein (the mutually exclusive folding model – discussed below). The
work in this chapter was performed in collaboration with Beena Krishnan and Alexandra
Walls.

4.1. The mutually exclusive folding principle and the suitable choice of host protein
In order to determine the thermodynamic stability of a protein inside the cell we have
attempted to construct a mutually exclusive folding (MEF) system consisting of a host
and test protein of our choice (see Figure 4.1) designed originally by Stewart Loh (Cutler
and Loh, 2007; Cutler et al., 2009; Radley et al., 2003). The MEF system works on the
basis that the coupling of the two proteins is architecturally incompatible. The differences
in distance between the site of insertion on the host and the N to C distance of the test
protein result in folding tug-of-war where both domains attempt to reach their individual
native states. However a native state can only be achieved by one domain at the energetic
cost of unfolding the other domain. Thus the ‘winner’ of this folding tug-of-war would be
the protein with larger equilibrium stability (Figure 4.1A) (Cutler and Loh, 2007).
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Furthermore such MEF systems can act as molecular switches where a change in
conditions can alter the folding equilibrium, thus selectively unfolding one of the two
proteins (Radley et al., 2003). The choice of change in condition we desire to exploit is
the stability imparted by the binding of a high-affinity ligand. Thus in our MEF scenario,
the stability of the test protein is poised between the stability of the apo-host protein and
the holo-host protein. Hypothetically, titration of the ligand would shift the population of
the host protein from apo to the holo state, thus increasing the stability of the host protein
relative to the test protein causing the test protein to unfold as a function of the
concentration of the ligand added (Figure 4.4 pages 157-158).
Figure 4.1 General design for a MEF system
A. The cartoon shows the simple design for a mutually exclusive folding construct with
two proteins, a host and a test. N-C termini of test (red arrows) are inserted into the host
at a surface loop causing architectural mismatch and setting up a folding tug-of-war.
B. One of our MEF constructs has DHFR as the host protein and Ubiquitin as the test
protein. Ubiquitin with its N-C distance of 37 Å is inserted into the DHFR surface loop
(between 106 – 107) with a distance of 6.7 Å. With this distance incompatibility, DHFR
and ubiquitin are now competing with each other to fold and the winner in this case will
be ubiquitin as it has the larger thermodynamic stability.
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4.2 Modified DHFR as a host protein
For the choice of host protein we have selected DHFR modified at the same surface loop
(between residues (106-107). This loop has also been manipulated in murine DHFR in a
fragment based recombination assay (Remy et al., 2007). It has been previously shown
that the DHFR fragmented at this loop can complement and can bind ligand (the two
fragments re-constitute the structure) (Remy et al., 2007). DHFR was a feasible choice
for the following reasons. First, the protein, while aggregation prone in vivo can be easily
refolded from inclusion bodies suggesting that if we can control the folding/aggregation
competition, we an obtain higher amounts of soluble protein inside the cell. Second, we
have characterized the folding stability of this protein in vitro at 37 o C (Chapter 2), and
the low stability value of 0.5 kcal/mol at 37 oC is desirable as a stability value to be at the
lower extreme of our MEF set up (the apo-test protein). Third, we know that the modified
DHFR is capable of binding the high affinity ligand trimethoprim (TMP) with nanomolar
affinity. A dissociation equilibrium constant in the range of 10-9 M imparts a stability
enhancement of approximately 12 kcal/mol (we can calculate this by using the formula
ΔG = -RTlnKd, where R is the gas constant, T the absolute temperature and Kd is the
equilibrium dissociation constant). Lastly, the ligand trimethoprim is highly specific for
DHFR and thus unlikely to interact with other proteins inside the cell, thus making the
system specifically tunable inside the complex environment of the cell. These four
properties allow us to consider DHFR as suitable host protein. Figure 4.1b shows an
example of a MEF construct where DHFR is the host protein and Ubiquitin is the test
protein inserted into the surface loop by its N and C termini. The distance incompatibility
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between the two proteins at the point of insertion sets up a folding tug-of-war, which is
the principle of the MEF design.

Furthermore, we tested the thermodynamic stability of the modified DHFR to determine
how much impact modifying the surface loop would have on the stability of this protein.
While we know that the protein is destabilized by approximately 3 kcal/mol at 37 oC
compared to wild type, this is only for one type of modification. To test the impact of
altering the loop length, we tested the stability of wildtype DHFR and compared to it the
stability of the gly-gly inserted variant and a variant with a (gly-gly-gly-ser)x2
(GGGS2)variant inserted in the same position. The idea behind expanding the loop was to
ask whether insertion of larger fragments would increasingly impact the already
perturbed stability of DHFR (Figure 4.2A, B, C). The increase in loop length was
hypothesized to minimally perturb stability, as it had no inherent structure, yet had an
entropic component that could affect stability. This would not be the case when a folded
domain would be inserted into the surface loop of DHFR (which would then be offset by
ligand binding DHFR – as designed in the MEF system). We tested the thermodynamic
stability of wildtype, GG and GGGS2 at 25 oC using urea denaturation experiments. The
stability of wildtype DHFR was calculated to be about 6.4 kcal/mol which is in good
agreement with the published value of 6.15 kcal/mol (Ionescu et al., 2000). The stability
of the GG and the GGGS2 variants was estimated to be 3.4 and 3.1 kcal/mol respectively
suggesting an appreciable reduction in stability compared to wildtype, but not when
compared to each other. These values of stabilities agree with our hypothesis that while
expansion of the loop with gly-gly perturbs stability significantly, further increasing the
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loop length does not further perturb stability drastically. These experiments suggest a
certain baseline to which DHFR would be destabilized as the host protein in the MEF
constructs.
Figure 4.2 Equilibrium stability of DHFR constructs with modified surface loops
A. Thermodynamic stability of wildtype DHFR at 25 0C is estimated to 6.4 kcal/mol.
B. The insertion of gly-gly residues at the surface loop reduces stability to approximately
3.4 kcal/mol.
C. Increasing the loop length with a (gly-gly-gly-ser)x2 causes no drastic alteration of
stability compared to the original loss of stability. In all panels the family of curves
shows the fluorescence spectra recorded between 320 and 380 nm after excitation of
tryptophan residues at 295 nm. The fluorescence at 344 nm is shown next to the family of
curves showing an equilibrium two state denaturation.
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4.2. The choice of reporter on the folded/unfolded state of the host or test protein.
In collaboration with Beena Krishnan and Alexandra Walls
In order to determine the status of the host or the test protein in our MEF system, we need
a signal which reports on the folded or the unfolded status of the either the host or the test
protein. We seek to build upon the existing fluorescence based methods to detect the
folded state of a protein. Previous attempts to measure the folded populations inside cells
have involved the use of the fluorophore Fluorescein Arsenical Hairpin binder (FlAsH)
binding to either a contiguous or a split tetra-cysteine motif present within the protein of
interest (Ignatova and Gierasch, 2004; Ignatova et al., 2007; Krishnan and Gierasch,
2008). Here we design a third generation of tetra-cysteine motif, where the cysteine
residues are inaccessible to the FlAsH fluorophore when the test protein is folded, but
upon being unfolded, are solvent exposed, and thus capable of binding the FlAsH
fluorophore. The quantum yield of FlAsH dramatically increases upon binding the tetracysteine motif and the signal can easily be differentiated from unbound FlAsH.

We chose to work with E. coli DHFR (our host protein), so that the ligand binding and
the reporter modules could be housed within one protein eventually. The other protein we
chose was human ubiquitin. We chose ubiquitin as one of our test proteins as well (see
below). In order to not perturb secondary structural elements of the protein, we
engineered the tetra-cysteine motif into loops of the proteins. In, DHFR loop 87-92 was
modified from DVPEIM to CCPECC. Similarly, in ubiquitin loop EVEPSD was

128

modified to CCEPCC (Figure 4.3A, C). The proteins modified to contain the tetracysteine (tetra-cys) motif are now dubbed TC-Ub (for ubiquitin) and TC-DHFR (for
DHFR) (Figure 4.3A, B). We hypothesize that the position of the tetra-cysteine motif
precludes the binding of FlAsH (low fluorescence intensity), and that the fluorophore
only binds upon the unfolding of the protein (high fluorescence intensity), thus reporting
on the unfolded populations of the proteins.

To test the stability of TC-Ub and TC-DHFR, 5µM protein was incubated with increasing
concentration of Guanidine hydrochloride (for TC-Ub) and Urea (for TC-DHFR). The
protein was allowed to incubate for 12 hours at 25 o C. FlAsH was added to a final
concentration of 0.5µM in the presence of the reductant ethane dithiol (EDT) to 50µM.
The high concentration of the reductant allowed us to assume equilibrium between free
FlAsH (conjugated with EDT) and bound FlAsH (bound to protein). The EDT also
prevents non-specific binding of FlASH to other proteins – a scenario likely to occur
inside the cell. The protein was allowed to incubate with the dye for 30 minutes prior to
fluorescence measurements. Fluorescence spectra were collected from 522 to 560 nm
after excitation at 508 nm. We found that the stability of TC-DHFR was approximately
2.5 kcal/mol which is a ΔΔG of 3.5 kcal/mol compared to wild type at the same
temperature (Figure 4.2). Ubiquitin stability was measured to be 4.7 kcal/mol, a value
which is within the stability range of apo and holo DHFR (Figure 4.3C, D).

Our next objective was to test whether the thermodynamic stability measured by change
in FlAsH fluorescence is comparable to the stability measured by other methods. This is
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particularly important for the test protein as any modifications can further perturb its
stability. We suspected based on previous studies that FlAsH binding does not heavily
perturb the folding equilibrium (Krishnan and Gierasch, 2008). Also, as the dye is added
in sub-stoichiometric amounts in the presence of a binding competitor (1,2-ethanedithol
(EDT)), we assume that FlAsH acts merely as a reporter of the unfolded state. We tested
this assumption by determining the stability of Ubiquitin in a FlAsH independent manner.
As ubiquitin has no native tryptophan residues we decided to use circular dichroism to
determine the stability of our tetra-cysteine ubiquitin construct. These experiments were
conducted in conjunction with Alexandra Walls, a former undergraduate in the
laboratory. To test the stability of TC-Ubiquitin, 1.5µM protein was incubated with
increasing concentration of Urea. The protein was allowed to incubate for 12 hours at 25
o

C. CD signal was collected from 250 to 210 nm and ellipticity at 222 nm was used to

calculate the stability of TC-Ub.

From our measurements monitoring the change in ellipticity as an output we determined
the stability of the ubiquitin construct to be 5.3 Kcal/mol. By comparing the stability
from FlAsh measurements and CD, the two values are comparable and support our
hypothesis that FlAsH binding does not significantly perturb stability (Figure 4.3E).
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4.3 Utility of FlAsH binding for stability measurements
A. Tetra cys DHFR modified at a surface loop (between residues 88-92, see text).
B. Thermodynamic stability of TC-DHFR calculated by measuring increase in FlAsH
fluorescence as a function of urea concentration. The fluorescence intensity rises with
increasing urea but drops at 2.5M. Stability calculated to about 2.5 kcal/mol by fitting to
the two state equation.
C. TC-Ubiquitin modified at a surface loop (between residues 17-22, see text).
D. Thermodynamic stability of TC-Ubiquitin calculated by measuring increase in FlAsH
fluorescence as a function of GdnCl concentration. Similar to TC-DHFR fluorescence
rises with increase in GdnCl, but drops after 4.5 M similar to TC-DHFR. Stability
estimated to 4.7 kcal/mol.
E. Estimation of TC-Ubiquitin by circular dichroism yields a value of 5.3 kcal/mol
indicating a mild perturbation of the stability of TC-Ubiquitin when measured with
FlAsH fluorescence.
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4.3. The choice of test proteins
One impediment of the MEF construct is the choice of test proteins that can be used.
There are three major limitations when choosing the test protein for the MEF construct,
the first being the stability of the test protein. If the stability of the test protein exceeds
the stability of the ligand bound host protein, there will not be a sufficient energetic
differential to unfold the test protein. Second is the size of the test protein. A multimeric
or a large sized protein which physically prohibits the re-union of the split host protein
will keep the test protein from refolding and binding the ligand, this will not allow the
MEF system to function as originally designed. The third limitation is the relative
kinetics of folding and unfolding between the host and test proteins. If the kinetics are
offset by a large difference, the unfolding of the test protein at the expense of folding the
host protein may not occur on a measurable timescale regardless of the differential
between the thermodynamic stabilities (Peng and Li, 2009).

All three of these limitations can be theoretically overcome by either, changing the host
protein to accommodate a larger stability difference between holo and apo forms of the
host protein or by varying the size of the host protein to better accommodate the test
protein. The choice of DHFR manages to address the first limitation somewhat
successfully as the stability of most proteins (with measured stability) lies between 4 and
12 kcal/mol which is within the stability range of apo (~0.5 kcal/mol) and holo (TMP
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bound ~12 kcal/mol by calculation of stability imparted by ligand binding) DHFR. The
kinetics of folding/unfolding will be intrinsic to the protein of choice and will not be
dissociable from the protein(s) used for the host and test. For our preliminary work, we
have chosen to work with two test proteins which are single domain and whose
thermodynamic stability lies between 0.5 and 12 kcal/mol. Furthermore, the N terminus
to C terminus distance for these proteins is significantly larger than the point of insertion
into DHFR, in agreement with the rationale for the MEF construct.

The first choice of test protein was TC-ubiquitin. With the stability of this construct
known (see section 4.2) and the N to C terminus distance of ~ 37 Å (compared to 6.5 at
the surface loop of DHFR, see Figure 4.1B), it was a viable candidate for a test protein
(Vijay-Kumar et al., 1987). Furthermore, with the tetra-cys motif reporting on the
unfolded state of ubiquitin we now have a readout on how the folding of DHFR impacts
the folding of ubiquitin by following FlAsH fluorescence. The second test protein we
used was superfolder GFP (sfGFP), with a reported thermodynamic stability of 9.1
kcal/mol and an N to C terminus distance of approximately 17 Å (Pedelacq et al., 2006).
Additionally, this test protein has the intrinsic advantage of being a self reporter as only
folded superfolder GFP produces fluorescence. Both proteins were cloned into the
surface loop of DHFR without any flanking linkers into pET16b vectors where the
expression of these proteins was driven from an IPTG inducible T7 promoter. As a
schematic we have depicted how the thermodynamic tug-of-war would play out inside
the cell using the DHFR-TC-Ubiquitin MEF construct. In the first scenario without any
ligand, a significantly larger fraction of the ubiquitin would be folded compared to
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DHFR, however, upon titration of the ligand, we would see a shift in these population to
now favor the folded form of DHFR, thus obligatorily unfolding ubiquitin exposing the
tetra-cys motif which will be detected by FlAsH fluorescence (Figure 4.4).

Figure 4.4 Schematic of the MEF system deployed inside cells
The cartoon shows a schematic of how the DHFR-TC-Ubiquitin MEF system can work
in vivo. In the first scenario the more stable test protein (TC-Ubiquitin) remains folded in
the absence of any DHFR stabilizing ligand. This sequesters the FlAsH binding site and
would show a low level of fluorescence. Upon introduction of the ligand trimethoprim
(pink), the MEF tug-of-war would now shift such that larger populations of DHFR are
folded, thus forcing the unfolding of the coupled TC-Ubiquitin exposing the FlAsH
binding site which would increase the fluorescence signal.
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4.4. Preliminary results
In our in vitro experiments with purified DHFR-TC-Ubiquitin (see methods), when the
DHFR-TC-Ubiqutin construct was titrated with increasing concentrations of
trimethoprim, 5µM protein was incubated with increasing concentration of trimethoprim.
The protein was allowed to incubate for 12 hours at 25 o C. FlAsH was added to a final
concentration of 0.5µM and EDT to 50µM. The protein was allowed to incubate with the
dye for 30 minutes prior to fluorescence measurements. Fluorescence spectra were
collected from 522 to 560 nm after excitation at 508 nm. According to our hypothesis, the
increase in the concentration of the ligand should partition increasing concentrations of
DHFR to the folded state thereby causing increasing the concentration of unfolded TCubiquitin that will be reported by an increase in FlAsH fluorescence. Indeed, we observed
an increase in FlAsH fluorescence with increasing TMP concentrations. This supports our
model that ligand binding drives the equilibrium towards DHFR folding and ubiquitin
unfolding (see Figure 4.5 A).

For our preliminary in vivo experiment we transformed DHFR-sfGFP into E. coli and
streaked them onto minimal media plates containing increasing concentrations of
Trimethoprim. An increase in the TMP concentration should drive the folding of DHFR
and thus necessarily the unfolding of the coupled GFP. The unfolding of GFP should
cause a decrease in GFP fluorescence. In good agreement with our MEF model, we
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observed a loss in fluorescence upon increasing the concentration of TMP. This result
showed promise to continue our work with the MEF system in vivo where the protein
folding equilibrium can be tuned by altering the concentration of the ligand (Figure 4.5
B).
Figure 4.5 In vitro and in vivo demonstrations of MEF constructs
A. MEF system works in vitro. As hypothesized, increasing TMP concentrations causes a
rise in FlAsH fluorescence indicating the unfolding of TC-Ubiquitin as a consequence of
DHFR folding. The molar ratio of DHFR-TMP indicates a 1 to 1 binding of the ligand to
DHFR. As a control experiment, the DHFR-Ubiquitin construct (without any tetra-cys
motif) does not show any change in fluorescence upon increase in TMP levels thus
showing the usefulness of the tetra-cys reporter.
B. E. coli cells transformed with DHFR-sfGFP construct were grown overnight on
minimal media containing increasing concentrations of TMP. Two main observations are
that the cells are able to grow on large amounts of TMP suggesting that the DHFR
provides some resistance to the high levels of TMP. Second, the GFP fluorescence is
reduced at higher TMP concentrations indicating the presence of folded DHFR and thus
unfolded sfGFP, which is unable to fold and fluoresce.
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4.5. Pitfalls in the MEF design
While the MEF system appears to have sound theoretical basis and has been shown to
work in preliminary experiments, there are certain challenges one has to consider when
working with this system. First, is the question of what it is that we are measuring? While
unfolding the test protein as a consequence of folding the host protein can be measured as
a function of the ligand, it is not truly the test protein that is being tested. The protein
being tested is now part of the MEF system that is a single chain system and not two
separate proteins. This introduces a penalty on the thermodynamic stability of the test
protein inserted into the system. This thermodynamic penalty is further examined by
Cutler and Lon (Cutler and Loh, 2007) and it is essentially the penalty for physically
coupling the two proteins exerted on the system. This changes the measured stability of
the test protein (ΔGtest) to a relative stability (ΔΔGtest) where ΔΔGtest is ΔGtest – ΔGx. In
this scenario, ΔGtest is the stability of the free test protein when not associated with the
MEF system and ΔGx is the thermodynamic penalty for insertion of the test protein into
the MEF system. The major disadvantage of this is that the ΔGx will have to be measured
for each construct made with the MEF system (due to the inherent differences in stability
amongst proteins and the varying levels of architectural incompatibilities introduced by
the varying N to C terminus lengths of the test proteins). Thus, only when the
measurements are made to obtain ΔGx can we deduce the stability of the test protein,
otherwise it will only be a relative measurement. This ΔGx can also vary in vivo where
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environmental factors (see Chapter 1) can influence the folding of the MEF construct.
However even without the measurement of ΔGx , the strategy would be useful to
determine the impact of mutations on the stability the test protein relative to wildtype as
the answer will be a ratio and not true numbers of stability.

Second, mutually exclusive folding constructs are highly aggregation prone in vivo. This
is not surprising as the design of the construct lends to a large fraction of either the test or
the host protein being unfolded. In the absence of any degradation, we have found that
MEF constructs expressed in E. coli are highly aggregation prone. We have seen that the
presence a TMP solubilizes a large portion of the dDHFR construct from chapter 2.
However, as we noted in the mathematical derivation (see below), the presence of any
amount of aggregated protein and the prevention of aggregation is intimately tied to the
intrinsic ratio of the folding and aggregation rate constants of the protein. Thus any
aggregation of the construct will not allow us to effectively separate the Kf (folding
equilibrium constant, a ratio of kf to ku – the folding and unfolding rate constants) and
kagg, the aggregation rate constant.

Recall from chapter two that the prevention of aggregation by the ligand is dependent on
the concentration of the ligand to a certain extent and the intrinsic folding vs. aggregation
propensities of the protein (Equation1). Furthermore, the impact of the ligand at very
high concentrations is limited by the ratio of the folding equilibrium constant to the
aggregation rate constant (Equation 2).
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f [A] ≅

€

1
k f ka [L]
1+
kagg (k u + k a [L])

(1)

At infinite ligand concentration equation 1 transforms such that

f [A] =

€

k agg (k u + ka [L])
=
k f k a [L] + k agg (k u + ka [L])

1
kf
1+
k agg

(2)

One potential solution to this is to purify the protein and exogenously introduce it into the
cell via a method like electroporation. Although this too does not ensure that the cellular
environment will not change the status quo of the MEF construct and cause it to
aggregate inside the cell. A similar issue exists with using the MEF construct in cell
lysates.

A potential solution to such problems is to design a muturally “inclusive” folding system.
Such a system has been reported in the joint efforts of the Bardwell – Radford groups
(Foit et al., 2009). The method they deploy is composed of a β-lactamase fused to the
protein of interest with sufficiently long linkers such that there is not architectural
incompatibility and the folding of the two proteins is independent. The system depends
on periplasmic degradation machinery of E. coli to rapidly degrade marginally stable test
proteins, and thus the associated β-lactamase . This decrease in β-lactamase levels is then
reflected in the ability of E. coli (transformed with the β-lactamase construct) to grow on
β-lactam antibiotics. If mutation in the test protein causes destabilization, that construct
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will be more susceptible to degradation and thus will not offer any protection against the
antibiotic. This system allows for the testing of impact of mutations on the stability of the
test protein in vivo but does not allow comparison between two entirely different test
proteins. Another way to approach the problem is by using NMR. Only in the last year
advances in measuring protein stability inside the cell using NMR have gained traction.
By either using fluorinated amino acids or by electroporating isotopically labeled protein
into cells have the effects of the cellular environment been tested on the stability of
proteins (Danielsson et al., 2015; Smith et al., 2016). Not unsurprisingly, protein stability
is affected although not drastically depending on the protein and the cellular environment
surrounding the protein, i.e. stability is context dependent. This is in good agreement with
the few reports on protein thermodynamic stability inside cells measure in the past
decade (Ebbinghaus et al., 2010; Guo et al., 2012; Guzman and Gruebele, 2014)
(Ghaemmaghami and Oas, 2001; Ignatova and Gierasch, 2004).

From Chapter 3 we learned the effect of various chaperones and the degradation enzyme
lon on the fate of one test protein. Our group has also reported similar effects for several
other test proteins. These observations highlight the importance of thinking about protein
folding inside the cell as a kinetic competition for the polypeptide chain. Thermodynamic
analyses and methods such as the MEF system will allow us to examine the impact of
mutations on proteins, but this impact will also be manifested in how the protein
partitions into folded or aggregated states or to the degree it is degraded. Thus an
approach that considers all potential fates of a protein inside the cell will ultimately yield
more information about how this process works inside the cell.
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4.6. Materials and Methods
• Cloning, protein expression and purification.
Cysteine free AS-DHFR was a gift from the Matthews lab (UMass Medical School,
Worcester MA). The gene was subcloned into the pET16b vector thus getting the protein
expression under the control of the T7-IPTG system. Insertions into the DHFR sequence
were performed by the introduction of NdeI and Xho I resctriction enzyme sites into
DHFR by the standard stratagene quickchange protocol allowing us to ligate desired
fragments between residues 106 and 107 of the translated protein.

Wildtype DHFR was purified using the following protocol
• Cell growth and protein induction
DHFR plasmid (pET 16b) was transformed into E. coli BL21(DE3) cells and a single
colony was used to start an overnight culture. 1.5% of the overnight culture was used to
start a fresh 1 L LB + Ampicillin (final 100ug/ml) culture. The 1 L culture was grown to
OD 600 of 0.6 at which point it was induced with a final IPTG concentration of 1mM for
4-5 hours. All growth and induction was done at 37 o C. Cells were harvested by
centrifugation at 4000 x g and resuspended in 20mM HEPES pH7.4 and flash frozen with
liquid N2 until further use.
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• Cell lysis:
Frozen cells were thawed under running cold water until completely thawed and then
were lysed using the microfluidizer. After being microfluidized, the lysed cells were
centrifuged at 20,000 rpm for 30 minutes and the insoluble fraction was discarded. The
soluble fraction was processed further.

• Ammonium Sulphate precipitation
The first step was to perform an ammonium sulphate precipitation of the protein and or
contaminants. Solid ammonium sulphate was gradually added to the supernatant after cell
lysis in 10% increments with slow stirring in 10 minute intervals. At 60% ammonium
sulphate, the protein (soluble DHFR) was mostly in the supernatant.
The 60% ammonium sulphate supernatant was resuspended in 20mM HEPES at pH 7.4
and dialyzed against 20mM HEPES at pH 7.4 to remove as much ammonium Sulphate as
possible before further treatment.

• DEAE column chromatography
The dialysate from the ammonium Sulphate precipitation was loaded a pre-equilibrated
DEAE anion exchange column (pre equilibrated with 20mM HEPES at pH 7.4. The
protein was loaded on the column and washed with 20mM HEPES at pH 7.4 and eluted
with a gradient ranging from 20mM to 1000 mM NaCl made in the HEPES. The eluted
sample was then dialyzed against 20mM Tris pH 7.4 and flash frozen and stored at -80 o
C till further use.
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All other DHFR related constructs were purified from inclusion bodies followed by the
same DEAE column chromatography used for wildtype DHFR.

• Extraction from inclusion bodies
After cell lysis and centrifugation, the supernatant was discarded and the precipitate was
washed with 0.1% Triton X-100 containing HEPES buffer at pH 7.4 to remove
membrane fractions. A second wash step was subsequently performed to remove any
triton from the first wash. The precipitate was then dissolved in 8 M urea made in 20 mM
HEPES at pH 7.4 for two hours until most of it dissolved. The unfolded protein from the
precipitate was then dialyzed against 20 mM HEPES pH 7.4 to remove the urea and
initiate protein refolding. The dialysate was further purified using the column
chromatography mentioned above.

• Equilibrium denaturation experiments:
For the DHFR variants, 3-5 µM protein was added to increasing concentrations of urea
and allowed to incubate overnight at 25 o C for a minimum of 12 hours. Unfolding of
DHFR was measured by tryptophan fluorescence after excitation at 295 nm followed by
acquiring spectra between 320 and 380 nm. Fluorescence intensity at 344 nm was used to
fit to the two state equation to determine equilibrium thermodynamic stability.
Similarly, for the tetra cysteine variants, the denaturation was performed using the same
procedure mentioned above with either increasing concentrations of urea or guanidine
hydrochloride. FlAsH fluorescence was measured after excitatation at 508 followed by
acquiring spectra between 520 and 560 nm. Intensity at 535 nm was used to fit to the two
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state equation to determine stability. Denaturation of TC-Ubiquitin was also followed
using circular dichroism by measuring the intensity at 222 nm which reports on the alpha
helical secondary structure.

• MEF experiments in vito and in vivo
• In vitro
Purified DHFR-TCUb (5 µM) was incubated with increasing concentrations of TMP and
allowed to incubate overnight at 25 o C. After a minimum of 10 hours of incubation,
FlAsH and EDT were added at a final concentration of 0.5 and 50 µM respectively.
Incubation with the fluorophore was allowed to occur for 30 minutes and FlAsH
fluorescence was subsequently measured. The same experiment was conducted with
DHFR-Ub (no tetra cys motif) to ensure that FlAsH fluorescence reports on the unfolding
of TC-Ubiquitin with high fidelity.

• In vivo
DHFR-sfGFP constructs were transformed into BL21(DE3) cells and the cells were
plated on minimal medium containing increasing concentrations of TMP. The plates were
incubated at 37 o C overnight and were imaged using eh syngene gel documentation
device.
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CHAPTER 5
QUO VADIS

5.1. Summary and conclusions
The questions which have motivated my research have a shared thread of understanding
how the in cell environment can alter the protein folding landscape. I have asked two
specific questions regarding the in vivo environment; the first was the impact of high
affinity ligands on the folding fate of proteins and the second was the impact of the
proteostasis network components on the folding fate of an obligatory chaperone
dependent client protein. To understand protein folding inside the cell and the impact of
the cellular environment on the protein, we have invoked a generalizable model of kinetic
partitioning which states that the synthesized polypeptide chain is partitioned between
correct folding, off-pathway intermediates which lead to aggregation, or degradation. All
three fates – folded, misfolded (aggregated) and degraded are a result of intrinsic protein
biophysical properties such as the rate constants governing each reaction. Upon this
generalizable model of kinetic partitioning we have overlaid either the effect of a high
affinity ligand – which then allows us to hypothesize the altered fate of the protein in the
presence of such a ligand or we have overlaid the proteostasis network which similarly
allows us hypothesize how chaperones and degradation machinery alter the folding fate
of the protein under consideration.

Using a combination of experiments and mathematical modeling, we were able to arrive
at several key conclusions regarding the impact of ligands and of the proteostasis
components on the folding of proteins inside the cell. First, we were able to
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mathematically deduce that the impact of a ligand was limited by the ratio of the intrinsic
folding to aggregation and/or degradation rate constants. Our tests using Trimethoprim
and 1-deoxygalactonojirimycin were able to experimentally determine this limit for a test
protein (DHFR) and for a protein linked to late onset Fabry disease (α-galactosidase)
respectively. Furthermore the results of this study also highlighted the importance of
understanding the kinetic partitioning when it comes to pharmacological chaperone
therapy along with the thermodynamic effects of the ligand. Finally this study now
provides a feasible model as to why certain protein mutations – mutations that hamper the
intrinsic folding of the protein are non-responsive to pharmacological chaperone therapy.

In the case of the impact of the proteostasis network on the folding of an obligatory
chaperone client, this is to our knowledge the first study, which seeks to address why
certain proteins have evolved to rely on chaperones to fold, while many others fold
spontaneously. Initial models from simulation experiments regarding the impact of
chaperone and degradation components were tested by experimentally varying the levels
of protein (MetK) and proteostasis components (GroELS, DnaKJE and lon). By varying
these components we shed light into the intrinsic propensity of our chaperone client to
aggregate, furthermore, we were also able to show how DnaK can work in collaboration
with GroEL to increase the pool of folded protein and finally how lon specifically targets
the misfolded state of MetK and acts to lower the concentration of aggregated protein.
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5.2. Significance of the findings
While our experiments and modeling have primarily been in E. coli cells, our results
especially about ligand binding have far reaching consequences. Importantly, the central
concept of kinetic partitioning can be used to describe the distribution and equilibria
governing protein folding and function inside the cell. One notable example of how
kinetic partitioning can manifest in disease is the case of cystic fibrosis. The CFTR
channel can be mutated in ways such that either the trafficking through the endoplasmic
reticulum is altered, or there is impairment of the function of the channel upon reaching
the membrane or the protein that reaches the membrane is rapidly degraded. All three
scenarios cause a loss of function for the cell, which is detrimental to health. By suitably
designing ligands such that either or all of the three pathways is/are targeted, we can now
hypothesize how the kinetic partitioning of CFTR can be altered to improve cellular
health. Secondly, several housekeeping and oncogenic proteins interact with cellular
quality control machinery. These include but are not limited to clathrin, tau, p53, and
STAT (Kasembeli et al., 2014; Trinidad et al., 2013; Yu et al., 2014). Mutations in these
proteins often result in gain of toxicity or loss of function diseases. Thus our knowledge
of how the proteostasis network deals with obligatory clients allows us to ask questions
about eukaryotic systems as well. For example, how does a p53 mutation affect its
interaction with the TRiC/CCT (the eukaryotic Hsp60) and how does that lead to disease?
Similarly such questions can also be asked of organellar proteostasis.
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5.3. Future directions:
The pharmacological chaperone work described in chapter 2 for the α-galactosidase
enzyme was initially pioneered by Amicus therapeutics, the company currently taking the
drug through phase 3 clinical trials as a small molecule therapy for Fabry disease. It was
their work with the small molecule that initially showed a rise in enzyme concentration
and activity upon treating cells expressing several mutant versions of α-galactosidase
responsible for Fabry disease. This would be a great platform for a collaboration where
the modeling approach we used in chapter 2 can be used to generate biophysical
information regarding several Fabry disease causing mutants. The input for these models
would theoretically be the enzyme activity – a surrogate for folded protein (or as in our
case, the fraction remaining) and the concentration of DGJ used to achieve those enzyme
activity levels. This would be a good database describing the folding/degradation
competition for several versions of a protein inside eukaryotic cells. Much of this
information can also be found in some of the work published by Amicus (Benjamin et al.,
2009; Wu et al., 2011). For continuing the work to understand how folding/aggregation
or degradation rate constants affect the impact of the ligand, future studies with known
DHFR mutants can be pursued using similar experimental approaches. We have not
characterized the folding or unfolding rate constants of the dDHFR construct used in our
study, however we can test the ligand approach on other DHFR mutants (such as the one
described by Cho et al. 2014) to further validate our system. Conversely, an attempt can
be made to purify sufficient amounts of the mutant α-GAL (R301Q) to characterize its
folding rate constant. Essentially, the ligand binding system can be further validated by
either testing the in vitro parameters of different mutants of either of our model proteins
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and by performing similar in vivo ligand titration experiments on other mutants of these
proteins.

Our experiments regarding the folding of MetK were performed in E. coli cells using
plasmids to overexpress the components under investigation. This approach allows
limited control of the levels of protein expressed and thus limits the amount of collectable
experimental data that can be fitted by FoldEco. To improve our understanding of the
impact of the proteostasis system we need a more precise way to control the
concentration of the components without drastically altering the protein folding reaction
going on inside the cell. Refolding experiments, where denatured protein is diluted into
conditions favoring folding will not be appropriate as they will not recapitulate the
involvement of the ribosome in synthesis and folding. To address this problem, we can
use an in vitro transcription and translation system, such as the PURE system to
synthesize the protein of choice while externally supplementing chaperones at the desired
concentration to determine their impact on folding. One good test protein to follow up on
would be MetK, as we can further probe how having GroEL influences the folding of this
protein. Similarly, given the abundance of information we have on CRABP I mutants and
their folding, we can use those as test proteins to better understand how varying the
biophysical properties changes chaperone dependence to fold successfully. The in vitro
nature of this experiment now allows us to examine multiple proteins in a more rigorous
fashion albeit in in vitro conditions which lack certain cellular complexities – particularly
molecular crowding and co-solutes.

155

One aspect where FoldEco is limited is in the number of proteins that can be tackled by
the program. Currently, FoldEco is designed to handle how the flux of one protein varies
during expression and how that protein relies on proteostasis network components based
on its intrinsic folding/misfolding parameters. Experimentally, we can start with the
introduction of two proteins and investigate how the proteostasis network would respond
to two entities folding simultaneously. Once we learn more about this, we can start
thinking about how we could express multiple proteins simultaneously and track their
folding fate inside the cell. These experiments would allow us to expand FoldEco to
incorporate the folding of multiple proteins inside the cell – which is what routinely
occurs under physiological conditions.

A further extrapolation of the folding of MetK investigated in chapter 3 is how this work
can be applied to proteins that heavily depend on the proteostasis machinery. This
scenario is likely to occur when proteins accrue destabilizing mutations leaving them
susceptible to aggregation. Previous work by the Hartl lab has shown how aggregation
prone proteins sequester metastable proteins thus causing a secondary gain of toxicity
phenotype. Furthermore these aggregates also tend to sequester chaperones that depletes
the proteostasis machinery leaving the entire proteome vulnerable to misfolding and
aggregation – or premature degradation, all scenarios detrimental for cellular health
(Walther et al., 2015) (Olzscha et al., 2011). Using our understanding of how a GroEL
substrate interacts with the chaperoning machinery inside the cell, we can now design
mutant versions to rely less or more on the chaperone components and thus alter the
burden on the proteostasis network. Alternatively, we can use proteins with diverse
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biophysical parameters with different chaperone dependencies as stressors for the
chaperone machinery. What this would allow us to do is ask the question, that if the
chaperones are engaged with the stressor protein, which proteins are left unprotected in
the proteome. Using quantitative mass spectrometry approaches such as isotopic labeling
in SILAC experiments or using multiple tandem mass tags, we can determine which
proteins are aggregation sensitive and to what extent when a stressor protein is introduced
into the cell. We can then extend this analysis to introduce a disease variant and ask
similar questions.

Lastly, the concept of kinetic partitioning can be applied to study protein folding in
eukaryotic systems. One avenue is to pursue the folding of lysozomal proteins and
systems where pharmacological chaperones are being investigated. However, another
area of interest would be the endoplasmic reticulum (ER) (Braakman and Hebert, 2013).
About a third of all proteins synthesized in eukaryotic cells are through the secretory
pathway (the lysosome also belongs to this general pathway). Furthermore, several
chaperones in the secretory pathway have been investigated extensively. Analogous to
the cytosolic version, the chief chaperone in the ER is BiP, which belongs to the Hsp70
family of chaperones. Additionally, there are other modifications such as the addition of
carbohydrates – which is also monitored by specific lectin binding chaperones. Finally,
some proteins are secreted from the cell to the outside of the cell. Thus a simplified
model, which involves kinetic partitioning, emerges from these factors. This models
encompasses synthesis, translocation into the ER, binding BiP and the carbohydrate
chaperones and secretion and the flux of the protein of interest through these points. Thus
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using particular readouts such as concentrations of chaperones, the concentrations of
proteins inside and outside the cell one can begin to build an understanding of how
protein folding works in the ER.

5.4. Experimental Caveats and potential ways to address them
For chapters two and three, where we study the impact of ligands or chaperones; we use
fraction aggregated as a readout for how the protein partitions between the folded and
aggregated state. Though we call our readouts as aggregated or soluble, they are in fact
placeholders for those properties. Our experimental methods allow for the separation of
insoluble (which we call fraction aggregate) and soluble (which we call fraction folded)
species after cell lysis. However, the insoluble and soluble are difficult to obtain cleanly
and can be comprised of several different species. For example, the soluble fraction can
be comprised of well-folded proteins, ligand bound proteins, protein molecules bound to
chaperones, soluble higher order species, and unfolded species. It is difficult to separate
the contribution of each of these species to the total population of the protein present in
the soluble state, however two main follow up experiments can be performed to
determine how the population of soluble protein is distributed. The first would be to
perform enzyme activity assays. We would assume that only well folded proteins (that
are enzymes like MetK) would show enzyme activity. This measurement would help
determine how much of the soluble pool is folded to the native state. The second
experiment would be to determine how much of the protein is distributed amongst the
cellular chaperone pool. In order to do this, one would require immunoprecipitation of
the chaperones and analysis of the contents bound to the chaperone. One has to be
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cautious during this experiment because the first step would be to deplete the ATP in the
soluble fraction so that the chaperone bound protein molecules remain trapped in the
chaperone and second, one has to try to precipitate almost all the chaperone molecules to
get a clear estimate of the population of proteins that are soluble and chaperone trapped.

Fraction aggregate measurements require the resuspension of proteins left insoluble after
cell lysis. Several times, the insoluble pellet will not be entirely resuspended by the
buffer, and the contents will not be homogeneously mixed. This is a potential source of
error for the measurement of the aggregated species. One way to overcome this is to
resuspend the insoluble fraction in a solution containing mild detergent or urea. This
treatment will help dissolve the insoluble species better and thus get a better handle on
the fraction aggregated. Additionally one can use a proteomic protein perpetually found
in the insoluble fraction as an internal control to compare across samples. This will serve
as a reference point for all samples and one can determine if the resuspension procedure
drastically varied between samples.
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APPENDIX
DERIVATION OF LIGAND BINDING AND DATA TABLES FOR CHAPTER
THREE
DERIVATION OF LIGAND BINDING– provided by Evan Powers
The derivation below shows the detailed steps of the model describing how the
effect of ligand binding (described in Chapter 2) can be explained by the ratio of the
intrinsic folding to aggregation or degradation rate constants. This derivation was
provided to us by Evan Powers.

The rate equations for this model are:
![!]
!"
![!]
!"
![!]
!"

= 𝜎 − 𝑘! 𝑈 + 𝑘! 𝑁 − 𝑘!"" 𝑈 − 𝑘!"# 𝑈

(1)

= 𝑘! 𝑈 − 𝑘! 𝑁 − 𝑘! 𝑁 𝐿 − 𝑘!"# 𝑁

(2)

= 𝑘!"" 𝑈

(3)

![!:!]
!"
![!"#]
!"
![!"#]
!"

= 𝑘! 𝑁 𝐿 − 𝑘!"# 𝑁: 𝐿

(4)

= 𝑘!"# 𝑈

(5)

= 𝑘!"# 𝑁 + 𝑘!"# 𝑁: 𝐿

(6)

where the bracketed symbols represent the concentrations of the corresponding states.
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Case 1: No ligand – and monitoring the fate of the aggregated protein
When no ligand is present but there is aggregation, degradation, and/or secretion of
protein, the terminal states are the aggregated, degraded, and secreted states. The amount
of unfolded and native protein within the compartment in which protein is produced will
eventually become negligible compared to the amount of protein in terminal states at long
times. However, the unbound native state will be a substantial fraction of the total protein
at earlier times. To understand the time-dependence of this system it is useful to break up
the protein expression time course into two time periods. In the first time period, the
amount of native protein is relatively small and ku[N] is small as well. As a consequence,
[U] fairly quickly reaches a “weak” pseudo-steady state in which the unfolding of native
protein is negligible (the pseudo-steady state is weak in the sense that it evolves to
another, more robust steady state on the time scale of the experiment). The value of [U] at
this pseudo-steady state can be determined from equation (1) by setting ku[N] = 0:
𝑈

!!,!

=!

!

(7)

!"" !!!"# !!!

This value for [U] can be inserted into equations (3) and (5), which can then be solved to
yield expressions for the rate of accumulation of aggregated and degraded protein during
the first period:
𝐴

!,!

𝐷𝑒𝑔

=!

!,!

!!"" !"

(8)

!"" !!!"# !!!

=!

!!"# !"

(9)

!"" !!!"# !!!
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The rate of accumulation of native protein inside the compartment depends on the rates of
folding and secretion and can be obtained by substituting the expression for [U]ss,1 into
equation (2) and solving the resulting differential equation to yield:
[𝑁]!,! = !

!!! !!!"# !

!! !
!"! !!!"# !!!

(10)

!!"#

Inserting this expression for [N]t,1 into equation (6) and solving the differential equation
yields the time dependent concentration of secreted protein:
[𝑆𝑒𝑐]!,! = !

!! !
!"" !!!"# !!!

𝑡−

!!! !!!"# !

(11)

!!"#

Note that when there is no secretion (ksec→0), equation (10) reduces to
[𝑁]!,! = !

!! !"

(12)

!"" !!!"# !!!

In the second time period, [N] will have gotten large enough that unfolding can balance
folding and a more robust pseudo-steady state is achieved. The concentrations of
unfolded and native states in this second time period can be determined by setting
equations (1) and (2) equal to 0 and solving:
𝑈

!!,!

=

𝑁

!!,!

=

! !! !!!"#
!!"" !!!"# !!"# !!! !!! !!"#

(13)

! !!

(14)

!!"" !!!"# !!"# !!! !!! !!"#

The rates of accumulation in the terminal states can be obtained by inserting these values
for [U]ss,2 and [N]ss,2 into equations (3), (5), and (6) and solving to give:
𝐴

!,!

=

! !! !!!"# !!"" !

(15)

!!"" !!!"# !!"# !!! !!! !!"#
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𝐷𝑒𝑔

𝑆𝑒𝑐

!,!

!,!

=

! !! !!!"# !!"# !
!!"" !!!"# !!"# !!! !!! !!"#

(16)

! !! !!"! !

=

(17)

!!"" !!!"# !!"# !!! !!! !!"#

The crossing over (temporally) from the first to the second time period happens gradually
and continuously. But one way to estimate the cross-over time is to set the right-hand
sides of equations (10) and (14) equal to each other and solve for t (time), which yields
!" !!

!!"" !!!"# !!! !!"#

𝑡! =

!!"# !!

!
!" !! !"# !

!!"" !!!"# !!

=

!!"#

!!

!!"" !!!"# !!

!!"#

!

=

!!

!" !!!!"# ! !!
!
!"" !!!"#
!!"#

(18)

where Kf = kf/ku is the equilibrium constant for folding and tc is the cross-over time. So
the time it takes to reach the second period depends on either 1/ku or on Kf/(kagg+kdeg),
whichever is larger. It also depends on ksec, but in a more subtle way because ksec appears
in both the numerator and the denominator. If ksec is large (secretion is fast), then tc will
be small, but if ksec is small or approaches 0—reflecting situations in which secretion is
slow or doesn’t happen at all—then tc will approach
!

𝑡! = ! + !
!

!!
! !!"" !!!"#

!

=! +!
!

!!

(19)

!"" !!!"#

Case 2: Irreversible ligand binding with ligand present at a constant concentration
When the volume of cells is small relative to the volume of the media, the media will
serve as a large reservoir of ligand for the cells. The free (unbound) ligand concentration
will then be effectively constant inside the cells (note that the concentration of ligand in
the cells and in the media may not be the same, but they should be proportional; that is,
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an n-fold increase in the ligand concentration in the media should result in an n-fold
increase inside the cells). Under these conditions, and if [L] >> Kd of the complex,
natively folded protein should bind effectively and irreversibly to the ligand so that [N:L]
accumulates while [N] quickly reaches steady state. Of course, this “steady state” is again
not a system-wide steady state because the concentrations of some species are changing,
so as before we will refer to it as a pseudo-steady state.
The pseudo-steady state concentrations of U and N are:
𝑈

!!

=

𝑁

!!

=

! !! !!! ! !!!"#
!!"" !!!"# !!"# !!! !!! [!] !!! !!"# !!! [!]
! !!
!!"" !!!"# !!"# !!! !!! [!] !!! !!"# !!! [!]

(20)

(21)

Inserting these expressions for [U] and [N] into equations (3) and (5) gives the following
for the pseudo-steady state rate equations for [A] and [Pdeg]:
![!]
!"

!!

= 𝑘!""

![!!"]
!"

!!

! !!"# !!! !!! [!]
!!"" !!!"# !!"# !!! !!! [!] !!! !!"# !!! [!]

= 𝑘!"#

! !!"# !!! !!! [!]
!!"" !!!"# !!"# !!! !!! [!] !!! !!"# !!! [!]

(22)

(23)

Solving these differential equations gives the following for the time-dependent
concentrations of A and Pdeg:
[𝐴]! =

!!!"" !!"# !!! !!! [!] !
!!"" !!!"# !!"# !!! !!! [!] !!! !!" !!! [!]

[𝐷𝑒𝑔]! =

!!!"# !!"# !!! !!! [!] !
!!"" !!!"# !!"# !!! !!! [!] !!! !!"# !!! [!]

(24)

(25)

Inserting the expression for [N]ss into equation (S4) and solving gives the time-dependent
concentration of N:L:
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[𝑁: 𝐿]! = 𝑘! 𝐿 𝑁!!

!!! !!"# !
!!"#

=

!!! !!!"#

!!! ! !!
!!"" !!!"# !!"# !!! !!! [!] !!! !!"# !!! [!]

(26)

!!"#

When there is no secretion (ksec = 0), this becomes
[𝑁: 𝐿]! =

!!! [!]!! !

(27)

!!"" !!!"# !! !!! [!] !!! !! [!]

Finally, inserting the expression for [N:L]t from equation (26) into equation (6) and
solving gives the time-dependent concentration of Psec:
𝑆𝑒𝑐

!

=

! !!
!!"" !!!"# !!"# !!! !!! [!] !!! !!"# !!! [!]

𝑘!"# + 𝑘! [𝐿] 𝑡 − 𝑘! [𝐿]

!!! !!!"# !
!!"#

(28)
When ksect >> 1, [Psec]t approaches
𝑆𝑒𝑐

!

=

! !!
!!"" !!!"# !!"# !!! !!! [!] !!! !!"# !!! [!]

𝑘!"# + 𝑘! [𝐿] 𝑡 −

!! [!]
!!"#

(29)

An observable for in vivo protein expression experiments.

Perhaps the most general and easily measured observable for in vivo protein folding in
the presence of a fast- and tight-binding ligand is the fraction of the total synthesized
protein that is neither aggregated nor degraded at a given time point. A general
expression for this quantity, which we shall denote Fr (for “fraction remaining”) is:
𝐹! = 1 −

[!]! ![!"#]!

(30)

[!"#]!

[Tot]t is simply equal to the protein expression rate multiplied by the time: [Tot]t = σt.
Inserting this and equations (24) and (25) into this equation yields
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!!!"" !!"# !!! !!! [!] !

𝐹! = 1 −

!

!!"" !!!"# !!"# !!! !!! [!] !!! !!"# !!! [!]

!!!"# !!"# !!! !!! [!] !
!!"" !!!"# !!"# !!! !!! [!] !!! !!"# !!! [!]

!"

(31)

This can be simplified to
!

𝐹! = 1 −
!!

!!
!!"" !!!"#

!

=1−
!!!!

!

!
!!
!!"# !! !
!
!!
!!

(32)
!

!!

!
!! !!! [!]

where B1 = kf/(kagg + kdeg), B2 = ksec/ku, and B3 = ka/ku. At very high ligand concentrations,
Fr approaches
!

𝐹!,[!]→! = 1 − !!! = 1 −
!

!
!!

(33)

!!
!!"" !!!"#

In the absence of ligand and at times such that t > tc (where tc is defined in equations
(S18) and (S19)), Fr is given by
𝐹! !!!!

! !!

=1−

!"" !! ,! ! !"# !! ,! ! !"" !!!! ,! ! !"# !!!! ,!
!!"! !

(34)

Inserting equations (8), (9), (15), and (16) into equation (34) and then collecting terms
gives

𝐹! !!!!

! !!

=1−

!!"" !!!"# !!! ! !!"" !!!"# !! !!!"# !!!!
!
!!"" !!!"# !!!
!!"" !!!"# !! !!!"# !!! !!"#

(35)

!"

Equation (34) can be simplified and rearranged to give:

𝐹! !!!!

! !!

!

=1−
!!

!!
!!"" !!!"#

!!"#
!! !!!"#

+

!!
!

(36)
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!
!!

!!
!!"" !!!"#

!!"#
!! !!!"#

−

!
!!

!!
! !! !!!"#

The quantity in parenthesis has to be positive (because ksec/(ku+ksec) < 1), but the third
term has to be less than the second term (because it has been stipulated that tc/t < 1), so Fr
< 1. Furthermore, Fr diminishes monotonically with time until, at very long times where
tc/t is very small, the third term can be dropped and Fr approaches the time independent
value:
𝐹! !!

!→! ! !!

=1−

!
!!

!!

(37)

!!"#
!! !!!"#

!!"" !!!"#

In terms of the constants B1, B2 and B3, equations (35) and (36) can be written as follows:
𝐹! !!!!

! !!

=1−

!
!!!!

!!
!!!!

+

!!
!

!
!!!!

!

!!
!!!!

− !!!

!

(38)

Substituting B1 into the expression for tc in equation (19) and then using the result as a
rough approximation for tc finally gives:
𝐹! !!!!

! !!

=1−

!
!!!!

!!
!!!!

!

+!

!!

!!!!
!!!!

!!
!!!!
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−1

(39)

[DnaK] M
[Arabinose] %w/v
0
0.002
0.02
0.2

Trial 1
67.1
138
513.9
751.4

Trial 2
62.5
204.3
482.7
626

Trial 3
85.1
195.2
434.6
593.8

[GroEL] M
[Arabinose] %w/v
0
0.005
0.02
0.2

Trial 1
109.1
619.2
739.4
1485.5

Trial 2
128.8
904.8
1438.9
1531.2

Trial 3
164.9
1348.5
1603.8
1603.8

[Lon] M
[Arabinose] %w/v
0
0.002
0.02
0.2

Trial 1

Trial 2

0
3.4
14.4
27.4

0
3.5
18.7
23.1

Trial 3
0
3
20.1
18.8

Table A.1 Chaperone concentrations upon induction
The above table shows the concentrations of chaperones achieved during each run of the
titration experiments in chapter 3 with the designated concentration of arabinose. The
concentration listed shows the concentration of the active form of the chaperone,
tetradecameric for GroEL, hexameric for lon and monomeric for DnaK.
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[IPTG] M
1
5
10
50
200

[MetK] M

Fagg

Trial 1

Trial 2

Trial 3

Trial 1

Trial 2

Trial 3

174.8
229
592.7
1139.9
1695.8

157.3
277.9
715
1354.9
1875.9

192.3
437.1
968.5
1777.9
2115.4

0.232
0.297
0.312
0.38
0.468

0.333
0.147
0.196
0.304
0.348

0.2
0.297
0.344
0.423
0.477

Average [GroEL]
Average [DnaK]
Average [Lon]

134 M
71 M
0 M

Table A.2 Concentrations and Fagg for MetK synthesized at varying IPTG
concentrations
The above table shows the concentration of MetK (monomeric) achieved under basal
conditions of proteostasis at the designated concentration of IPTG and the fraction of
MetK which aggregates at each concentration of MetK synthesized.
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[MetK] M

Fagg

[IPTG] M

Trial 1

Trial 2

Trial 3

1
5
10
50
200

139.7
245.1
658.3
1161.4
1754.2

216.1
209
523
1380.5
1940.5

187
297.5
577.4
1811.6
2188.2

[DnaK] M
179

Trial 1
0.185
0.217
0.251
0.441
0.401

[MetK] M
[IPTG] M
[DnaK] M
477

1
5
10
50
200

Trial 1

Trial 2

Trial 3

204.6
290
436.6
1186.7
1800.3

158.4
187.8
500.3
1410.5
1991.5

138.8
300
550
1851
2245.7

[DnaK] M
657

1
5
10
50
200

Trial 1
122.2
204.8
315.4
1119.2
2091

Trial 3

0.262
0.3604
0.263
0.3
0.392

0.268
0.196
0.301
0.333
0.419

Fagg
Trial 1
0.027
0.223
0.201
0.209
0.243

[MetK] M
[IPTG] M

Trial 2

Trial 2
0.249
0.297
0.238
0.216
0.74

Trial 3
0.196
0.204
0.352
0.242
0.513

Fagg

Trial 2

Trial 3

192.5
189.6
438.5
1330.3
1854.2

237.6
332
555
1745.8
1676.2

Trial 1
0.127
0.2
0.09
0.107
0.472

Trial 2
0.048
0.197
0.109
0.12
0.26

Trial 3
0.118
0.172
0.202
0.165
0.229

Table A.3 Concentrations and Fagg for MetK synthesized at varying IPTG
concentrations at varying DnaKJE concentrations
The above table shows the concentration of MetK synthesized in the DnaKJE titration
experiments. The average DnaK concentration is the left most column and the
concentration of MetK synthesized (at the designated concentration of IPTG) and the
fraction aggregated for each experiment is listed.
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[MetK] M
[IPTG] M
[GroEL] M
957

1
5
10
50
200

Fagg

Trial 1

Trial 2

Trial 3

192
310.7
1199.4
1148.3
2238.4

136
302.7
896.5
1364.9
1984.9

212
354.3
1395.5
1791.1
1794.4

Trial 1
0.072
0.087
0.188
0.122
0.26

[MetK] M
[IPTG] M
[GroEL] M
1260

1
5
10
50
200

Trial 1
128.9
338.8
1099.8
1159.2
1810.7

[GroEL] M
1540

1
5
10
50
200

Trial 1
67.4
83.9
315.8
1152.9
1635.2

Trial 3

0.353
0.088
0.038
0.027
0.215

0.104
0.404
0.195
0.155
0.24

Fagg

Trial 2

Trial 3

110.8
306.4
843.5
1378
2003

173.4
368.2
1145.9
1808.2
2258.8

Trial 1
0.281
0.047
0.032
0.179
0.343

[MetK] M
[IPTG] M

Trial 2

Trial 2

Trial 3

0.359
0.038
0.102
0.042
0.245

0.216
0.05
0.183
0.102
0.154

Fagg

Trial 2

Trial 3

46
72
354.7
1370.4
1808.8

46.5
77
301.8
1798.3
2039.7

Trial 1
0.136
0.428
0.198
0.291
0.117

Trial 2
0.143
0.302
0.174
0.13
0.175

Trial 3
0.257
0.222
0.124
0.272
0.143

Table A.4 Concentrations and Fagg for MetK synthesized at varying IPTG
concentrations at varying GroELS concentrations
The above table shows the concentration of MetK synthesized in the GroELS titration
experiments. The average GroEL concentration is the left most column and the
concentration of MetK synthesized (at the designated concentration of IPTG) and the
fraction aggregated for each experiment is listed.
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[MetK] M
[IPTG] M
[Lon] M
3.3

1
5
10
50
200

Trial 1

Trial 2

344.2
390.4
536.5
982.6
1811.5

263.5
355.8
413.5
888.6
1696.1

Fagg
Trial 3
390.4
401.9
559.6
817.1
1719.2

Trial 1
0.26
0.278
0.35
0.373
0.556

[MetK] M
[IPTG] M
[Lon] M
17.7

1
5
10
50
200

Trial 1
263.5
150
228.9
612.9
1282.7

Trial 2
240.4
213.5
263.5
511.4
1215.4

[Lon] M
23

1
5
10
50
200

Trial 1
138.5
171.1
182.7
698.6
1053.8

Trial 2
171.1
205.8
228.9
630
882.7

Trial 3

0.344
0.397
0.414
0.386
0.494

0.338
0.315
0.448
0.332
0.464

Fagg
Trial 3
251.9
159.6
217.3
494.3
951.9

Trial 1
0.14
0.21
0.261
0.196
0.25

[MetK] M
[IPTG] M

Trial 2

Trial 2
0.047
0.129
0.345
0.318
0.291

Trial 3
0.192
0.153
0.116
0.119
0.38

Fagg
Trial 3
140.4
152
182.7
592.9
905.8

Trial 1
0.116
0.119
0.12
0.202
0.211

Trial 2
0.106
0.158
0.13
0.192
0.247

Trial 3
0.116
0.206
0.179
0.141
0.103

Table A.5 Concentrations and Fagg for MetK synthesized at varying IPTG
concentrations at varying Lon concentrations
The above table shows the concentration of MetK synthesized in the Lon titration
experiments. The average Lon concentration is the left most column and the
concentration of MetK synthesized (at the designated concentration of IPTG) and the
fraction aggregated for each experiment is listed.
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